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with poor collaterals, p = 0.002). Correspondingly, most patients (11/16) with
penumbra<66% had poor collateral status, versus 5/20 with penumbra > 66%
(p = 0.02). Of the 15 patients with penumbra > 66% and good collateral
status, eight had an excellent outcome (mRS 0–1) compared with 0/5 with
penumbra > 66% and poor collaterals (p = 0.05).
Ten of 15 patients with major reperfusion at 24-h had a good outcome, versus
2/21 without (p < 0.001). However, major reperfusion was predominantly
beneficial in patients with good collateral status, 9/10 with good collaterals
and major reperfusion had a good outcome, versus 1/5 with major reperfu-
sion and poor collaterals (p = 0.008).
Conclusion: Patients with a large penumbra have a high probability of good
clinical outcome provided they also have good collateral status, and subse-
quent reperfusion occurs.
New Investigator Award – Session 1
Wednesday, 13 August 2008: 1200–1215 h
OUTCOMES OF TRANSIENT ISCHEMIC ATTACK ADMITTED TO A
STROKE UNIT
AW Lee, CS Chen, G Grantham, D Schultz, D Thyagarajan
Flinders University, Department of Neurology, Flinders Medical Center
and the Repatriation General Hospital, SA
Background and Aims: Transient ischemic attacks (TIA) may progress to
a completed stroke. Opinion is divided on how best to prevent this in terms
of admission versus an outpatient rapid assessment service for TIA evalua-
tion.The ABCD score has been used to stratify TIA patients into high versus
low risk of stroke progression. We aim to evaluate the utility of such a score.
Methods: A retrospective cross sectional study was conducted of consecu-
tive admitted TIA patients in a Calendar Year (2006–2007).The ABCD score,
length of hospital stay, progression to a completed stroke and other signifi-
cant variables were recorded.
Results: Eighty three TIA subjects (43 males) with a mean age of 75.3 ±
11.5 years were analysed. The median ABCD score was 5 (IQR = 4–5) with
a mean length of stay of 4.1 ± 3.1 days. Four subjects (4%) progressed to
ischemic stroke. No association between ABCD score and stroke progression
was observed (p = 0.531). The presence of a carotid artery stenosis of >70%
(p < 0.0001) and the absence of anti platelet use (p = 0.095) were associated
with stroke progression post TIA. No haemorrhages were seen on CT brain
scanning.
Conclusion: No association was found between ABCD score and the risk
of stroke progression which was low. Furthermore, hospital length of stay was
relatively long. If a carotid Doppler could be performed on initial evaluation
and anti platelet agents given following brain CT, then it is possible that TIA
evaluation could be completed as an outpatient, avoiding the not inconsid-
erable costs of a hospital admission.
New Investigator Award – 
Session 1
New Investigator Award – Session 1
Wednesday, 13 August 2008: 1130–1145 h
IS TRANSCRANIAL DOPPLER MONITORING OF VASOSPASM IN SUB-
ARACHNOID HAEMORRHAGE CLINICALLY USEFUL?
Xiaowei Wang, Gavin Davis, Greg Fitt, Brian Chambers
Austin Health, National Stroke Research Institute, University of Mel-
bourne, VIC
Background: Controversy surrounds the clinical utility of transcranial
Doppler (TCD) monitoring for vasospasm in patients with aneurysmal sub-
arachnoid haemorrhage (SAH). Our aim was to determine whether reaching
TCD thresholds for vasospasm changed patient management.
Methods: We evaluated patients admitted to the Austin Hospital with SAH
who underwent surgical clipping or endovascular coiling of an aneurysm and
serial TCD monitoring. Vasospasm was defined as mean blood flow velocity
(MV) ≥120 cm/s and Lindegaard ratio (LR) ≥3, and severe vasospasm as MV
≥200 cm/s and LR ≥6. The accuracy of TCD was determined by compari-
son of TCD with angiography performed within the same 24-h period. We
also assessed whether the TCD detection of vasospasm triggered angiogra-
phy within the next 48 h, and the time of onset of symptomatic vasospasm
relative to TCD-detected vasospasm.
Results: A total of 84 patients (mean age 53 years; 64% female) were
studied. TCD demonstrated no vasospasm in 22%, mild to moderate
vasospasm in 51% and severe vasospasm in 27%. 50 patients underwent a
total of 76 angiograms. For middle cerebral artery (MCA) and anterior cere-
bral artery (ACA) vasospasm, there was moderate agreement between TCD
and angiography (Kappa = 0.41 [MCA], 0.38 [ACA]). Angiography was
more likely to be performed when TCD detected severe vasospasm (p =
0.029). TCD detected vasospasm on average 1.7 days before the onset of
clinical signs.
Conclusion: TCD results were utilized to select patients for angiography
following clipping/coiling of a ruptured aneurysm.TCD detected vasospasm
before clinical deterioration, providing a therapeutic window of opportunity.
New Investigator Award – Session 1
Wednesday, 13 August 2008: 1145–1200 h
DOES COLLATERAL VESSEL STATUS ON CT ANGIOGRAPHY ADD TO
PERFUSION CT IN THE PREDICTION OF OUTCOME AFTER ACUTE
ISCHAEMIC STROKE?
F Miteff, MW Parsons, GA Bateman, N Spratt, CR Levi
Departments of Neurology and Radiology, John Hunter Hospital,
Hunter Medical Research Institute, University of Newcastle, NSW
Objectives: To assess how perfusion CT (CTP) lesions and CT angiogra-
phy (CTA) collateral vessel status relate to clinical outcome in acute
ischaemic stroke.
Methods: Patients underwent CTP and CTA within 6 h of acute ischaemic
stroke, MRI at 24 h, and 3-month modified Rankin Scale (mRS). Patients
were included if baseline imaging showed a perfusion lesion and intracranial
vessel occlusion.
Results: Thirty-six patients were included, (mean age 71.6 years, median
acute National Institutes of Health Stroke Scale 16). No patient (n = 16)
with baseline penumbra <66% of the total perfusion lesion had a good 3-
month outcome (mRS 0–2), whereas a good outcome occurred in 12 of 20
patients with a baseline penumbra > 66% (p < 0.001). Baseline infarct core
was much smaller in the good collateral group (median 18 cm3 versus 73 cm3
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New Investigator Award – Session 1
Wednesday, 13 August 2008: 1215–1230 h
DENSITY HETEROGENEITY: A NOVEL INDEPENDENT CT GROWTH
PREDICTOR IN INTRACEREBRAL HAEMORRHAGE
CDJ Barras, S Christensen, L MacGregor, BM Tress, M Collins, SM
Davis; for the Recombinant Activated Factor VII (rFVIIa) Intracerebral
Hemorrhage Trial Investigators
Departments of Neuroscience and Radiology, Royal Melbourne Hospi-
tal, The University of Melbourne, VIC
Background: Intracerebral haemorrhage (ICH) growth predicts mortality
and functional outcome. We hypothesised that irregular haematoma shape
and density heterogeneity, reflecting multiple bleeding foci and/or a variable
bleeding timecourse, would predict ICH growth.
Methods: Three raters examined baseline sub-3 h CT brain scans of 90
patients in the placebo arm of the Phase IIb trial of rFVIIa in ICH. Each
rater, blinded to growth data, independently applied novel 5-point categori-
cal scales of shape and density to randomly presented CT images of ICH.
Reliability studies were performed. Growth was assessed as a continuous vari-
able and using 3 binary definitions, between baseline and 24 h CT scan.
Patients were divided into baseline volume tertiles: ‘small’ (0–10 mL),
‘medium’ (10–25 mL) and ‘large’ (25–106 mL).
Results: Inter-rater agreements exceeded 85% (±1 category). Median
growth was higher in large volume compared with small volume bleeds (p <
0.001) and in heterogeneous (category 3–5) compared with homogeneous
(category 1–2) ICHs (p = 0.008). Median growth trended higher in irregu-
lar (category 3–5) ICH, compared with regular (category 1–2) ICHs (p =
0.084). Small ICHs were more regularly shaped (43%) than the medium
(17%) and large (3%) ICHs (p < 0.001). Small ICHs were more homoge-
neous (73%) compared with medium (37%) and large (17%) ICHs (p <
0.001). After adjustment for baseline volume and time to scan, density het-
erogeneity independently predicted ICH growth (p = 0.046) using some
growth definitions.
Conclusions: Large ICHs were significantly more irregular in shape, het-
erogeneous in density, and grew more. Shape irregularity and density het-
erogeneity are features of ICH expansion. Density heterogeneity may predict
ICH growth.
New Investigator Award – Session 1
Wednesday, 13 August 2008: 1230–1245 h
DYNAMIC CHANGES IN THE NEUROCARDIOGENIC AXIS IN ACUTE
ISCHAEMIC STROKE
W O’Brien, T Wong, M Brown, J Sturm, S Whyte, S Williams, 
M Williams, D Crimmins
Gosford Hospital, Gosford, NSW
Background: Acute ischaemic stroke (AIS) has cardiovascular effects
including catecholamine rise, ECG abnormalities, and a transient rise in
cardiac humoral biomarkers thought to represent cardiac dysfunction. To
date, information is lacking about left ventricular function at intervals post
AIS.
Aims: To investigate transient cardiac dysfunction in AIS using serial BNP,
troponin, 3D Trans-thoracic Echocardiogram and 48 h holter monitoring.
Methods: Patients admitted post AIS or Transient Ischaemic Attack (TIA)
were prospectively assessed with a 48 h holter monitor; 3D TTE at Day 1
and Convalescence (5–7 days) to measure end diastolic volume (EDV), end
systolic volume (ESV), stroke volume (SV) and ejection fraction (EF);
NT-Pro BNP and troponin concentrations were measured at Day 1, 2 and
Convalescence (day 5–7).
Results: 48 patients were studied, 37 with stroke and 11 with TIA. NT-Pro
BNP concentrations were (mean ± SE) (n = 48) 1601.08 pg/mL (±483.92)
Day 1 and fell to 800.47 pg/mL (±312.59) in Convalescence (p < 0.001). 3D
echo volumetric analysis was available from D1 and Convalescence in 33
patients. Day 1 3D echo results (mean ± se) were EDV = 80.94 (±4.94), ESV
= 36.25 (±3.79), EF = 56.91 (±1.79), SV = 44.36 (±2.19). Convalescence
3D echo results were EDV = 89.90 (±5.88) (p = 0.016), ESV = 37.61 (±4.23)
(p = 0.47), EF = 59.90 (±1.93) (p = 0.05), SV = 51.90 (±2.63) (p = 0.007).
Conclusion: Along with the transient rise in NT-Pro BNP concentrations,
there are significant changes in cardiac dimensions as measured on 3D echo.
Left ventricular stroke volume, end diastolic volume and ejection fraction are
transiently reduced in AIS, which has not been documented previously.
New Investigator Award – Session 1
Wednesday, 13 August 2008: 1245–1300 h
INVESTIGATION OF THE PUTATIVE NEUROPROTECTANT EFFECT OF
THE NEUROSTEROID ALLOPREGNANOLONE AFTER STROKE
Amelia Tomkins, Debbie Pepperall, Mike Calford, Neil Spratt
University of Newcastle, NSW
Aim: The neurosteroid allopregnanolone is synthesised from progesterone
in brain neurons. It is the most potent known modulator of the gamma-
aminobutyric acid (GABA) receptor (increasing neuronal inhibition), and is
upregulated in models of excitotoxicity. As an endogenously synthesised com-
pound, allopregnanolone is an appealing neuroprotectant and data from 
multiple brain injury models, including stroke models, suggest that both 
allopregnanolone and progesterone are neuroprotective. Using rigorous
experimental design in a well-established model of stroke we aimed to
confirm the effectiveness of allopregnanolone in reducing infarct volume.
Methods: A well-established thread-occlusion model of stroke was used with
spontaneously hypertensive rats (SHRs) and a 90-min middle cerebral artery
occlusion (MCAo). After vessel reperfusion, animals were randomised to
treatment with allopregnanolone (8 mg/kg, n = 12), progesterone (8 mg/kg,
n = 13) or vehicle (cyclodextrin 540 µL, n = 13), administered intraperi-
toneally 110 min, and subcutaneously 6 h after MCAo. Post-operatively
animals were maintained in cages 1/2 over a heating mat for 6 h, and tem-
perature measured at 2, 6 and 24 h Histological assessment was performed
on haematoxylin and eosin stained sections and infarct volumes calculated
according to standard methodologies. All investigators were blind to treat-
ment allocation until data collection was complete.
Results: and Discussion: Infarct volumes in the allopregnanolone, proges-
terone and vehicle groups were very similar. These results differ significantly
from previously published studies of neuroprotection by both allopreg-
nanolone and progesterone. Methodological differences may explain these
discrepancies.
Conclusions: This study raises doubts about the suggested neuroprotection
by allopregnanolone and progesterone. Further studies are underway to
investigate possible mechanisms for previous apparent neuroprotection.
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Concurrent 1
Concurrent 1 – Platform Session
Wednesday, 13 August 2008: 1400–1415 h
ROLE FOR NOTCH-1 SIGNALING IN ISCHEMIC STROKE-INDUCED
ENDOTHELIAL CELL DYSFUNCTION
Thiruma V Arumugam1, Pradeep K Selvaraj1, John Thundyil1, 
Mark P Mattson2
1Department of Pharmaceutical Sciences, Texas Tech University Health
Sciences Center, Amarillo, TX, USA; and 2Laboratory of Neurosciences,
National Institute on Aging Intramural Research Program, Baltimore,
MD, USA
Background: Previously we showed that Notch antisense mice and mice
treated with δ-secretase inhibitors exhibited reduced ischemic lesion and
improved functional outcome in a focal ischemic stroke model (Nat Med.
2006; 12(6): 621–3.). However, it is not known whether Notch-1 influences
ischemic stroke-induced brain endothelial activation and dysfunction.
Hypothesis: This project investigates the hypothesis that, brain endothelial
Notch-1 signaling contributes to the neurovascular inflammatory response.
Methods: Here we use human microvascular endothelial cells (HMECs),
mouse brain endothelial cells (MBECs) and in vivo models of ischemic stroke
to elucidate roles for Notch-1 in ischemic stroke-induced endothelial 
dysfunction.
Results: Preliminary data show that Notch-1 and the Notch ligand Jagged
expression increase during the first few hours in glucose deprivation (GD)
and oxygen and glucose deprivation (OGD) conditions in both HMECs and
MBECs. We also observed increased levels of the Notch signaling-induced
transcription factors (Hes) in response to GD and OGD. We are currently
studying the role of increased Notch signaling in endothelial dysfunction in
a mouse model of ischemic stroke.
Conclusion: The identification of involvement of Notch-1 in endothelial cell
dysfunction following ischemic stroke will yield potential neurovascular
targets for therapeutic interventions in ischemic stroke.
Concurrent 1 – Platform Session
Wednesday, 13 August 2008: 1415–1430 h
ASSESSMENT OF THE NEUROPROTECTIVE EFFICACY OF POST-
ISCHAEMIC MILD HYPOTHERMIA (35°C) AND MAGNESIUM FOLLOW-
ING GLOBAL AND FOCAL CEREBRAL ISCHAEMIA IN RATS
Kym Campbell, Bruno P Meloni, Hongdong Zhu, Luke Robinson,
Neville W Knuckey
Department of Neurosurgery/Sir Charles Gairdner Hospital, Centre for
Neuromuscular and Neurological Disorders/University of Western Aus-
tralia and Australian Neuromuscular Research Institute, Nedlands, WA
Abstract not to be published.
Concurrent 1 – Platform Session
Wednesday, 13 August 2008: 1430–1445 h
CEREBRAL INFARCT SIZE IS GENDER-DEPENDANT FOLLOWING
TRANSIENT BUT NOT PERMANENT MIDDLE CEREBRAL ARTERY
OCCLUSION IN MICE: DIFFERENTIAL EFFECTS ON NOX1, NOX2 AND
NOX4 EXPRESSION
CG Sobey, VH Brait, KA Jackman, AE Mast, TM DeSilva, AA Miller, 
GR Drummond
Department of Pharmacology, Monash University, Melbourne, VIC
Females are strongly protected against cerebral ischemia-reperfusion (I-R)
damage but the underlying mechanisms are poorly understood. Moreover,
it is not clear whether females are similarly protected during ischemia with
no reperfusion (I-NR). Here we have tested whether females are protected
to a similar degree during both cerebral I-R and I-NR, and whether the out-
comes are associated with changes in expression of NADPH oxidase Nox
subunits in the ischemic brain. Stroke was induced by 0.5 h middle cerebral
artery occlusion in 6–8 week-old female and male C57Bl6J mice. After 24 h,
brain infarct volume was measured in thionin-stained coronal sections. After
I-R, males had a larger infarct volume than females (55 ± 11 vs 24 ± 6 mm3;
P < 0.05), whereas there was no gender difference following I-NR (88 ± 11
vs 88 ± 9 mm3). After I-R in males, expression of Nox2 increased by ∼30%
and Nox4 decreased by ∼20%, whereas in females neither isoform was altered
by I-R. After I-NR in males, changes in Nox2 and Nox4 were slightly more
pronounced than after I-R (+60% and −25%, respectively). However in
females, in contrast to the lack of effects on brain Nox2 and Nox4 expres-
sion after I-R, marked changes occurred after I-NR (+70% and −40%,
respectively). There were no differences in Nox1 expression between any 
of the groups. Thus, cerebral infarct size is gender-dependent following I-R
but not I-NR in mice. The lack of protection in females after I-NR is asso-
ciated with changes in brain expression of Nox2 and/or Nox4 not present
after I-R.
Concurrent 1 – Platform Session
Wednesday, 13 August 2008: 1445–1500 h
OPTIMIZING MISMATCH DEFINITIONS IN ACUTE STROKE MRI – AN
EPITHET POST HOC STUDY
Soren Christensen, Mark W Parsons, Deidre A De Silva, Martin Ebinger,
Ken Butcher, John Fink, Patricia Desmond, P Alan Barber, C Bladin, 
C Levi, Geoffrey A Donnan, Stephen M Davis
Royal Melbourne Hospital, University of Melbourne, VIC
Background: The recently published EPITHET trial tested whether tissue
plasminogen activator (tPA) attenuated growth in patients with a perfu-
sion/diffusion weighted imaging mismatch, believed to identify potential
treatment responders.The trial was negative for the primary growth outcome
measure. Secondary outcome measures consistently showed a tendency for
improved outcomes in the tPA group.
Aims: Eighty-six percent of patients had mismatch, and we hypothesized that
a more restrictive mismatch definition would identify an enriched population
with larger treatment response. In this descriptive post-hoc analysis we inves-
tigated the effect of changing the Tmax and mismatch ratio definitions in
order to identify effect sizes, definitions and outcome measures for use in
future studies.
Methods: Mismatch definitions were varied to identify subpopulations with
mismatch frequencies from 10 to 100%. We recorded effect and significance
level of the differences between treatment arms at each definition. Outcome
measures were infarct growth and mRS 0–1.
Results: More restrictive mismatch definitions were significantly correlated
with larger growth differences between treatment arms R2 = 0.40 (P < 0.001)
and identified a population with higher treatment response.
The odds ratio for mRS 0–1 in the tPA arm showed a much weaker corre-
lation R2 = 0.09 (P < 0.001) with mismatch definitions and although there
was a constant trend for benefit of tPA, the group differences were not sig-
nificant at any relevant threshold.
Conclusion: More restrictive mismatch definitions identify subgroups of
patients in EPITHET with higher and significant response to treatment.
Based on EPITHET 360 patients are required to demonstrate effect on clin-
ical outcomes.
Concurrent 2
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Concurrent 1 – Platform Session
Wednesday, 13 August 2008: 1500–1515 h
WHITE MATTER HYPERINTENSITIES AND COGNITIVE FUNCTION –
THE TASMANIAN STUDY OF COGNITION AND GAIT (TASCOG)
Jennifer Stapleton1,3, Michael Saling3, David Reutens1, Richard Beare1,
Thanh Phan1, Velandai Srikanth1,2
1Department of Medicine, Monash Medical Centre, Melbourne, VIC;
2Menzies Research Institute, University of Tasmania, Hobart, TAS; and
3School of Behavioural Sciences, University of Melbourne, Melbourne,
VIC
Background: White matter hyperintensities (WMH) are commonly seen on
magnetic resonance imaging (MRI) scans of older adults. The cognitive
effects of WMH remain uncertain with some data suggesting that executive
function and processing speed are particularly vulnerable.There are few data
on this issue from population-based samples using volumetric imaging.
Aims: To determine the effects of WMH on cognition in a large population-
based sample of older adults.
Methods: Participants (n = 413) were randomly recruited from the Tas-
manian electoral roll and underwent a cognitive test battery and volumetric
brain MRI.Those with incidental brain lesions, poor quality MRi and stroke
lesions were excluded. Cognitive factors representing general cognition,
speed, executive/attention ability, memory and visuospatial ability were gen-
erated using factor analyses. A semi-automated approach was used to obtain
WMH volume (WMHv) from. Linear regression was used to study the effects
of WMHv on cognitive factors.
Results: The mean age of the sample was 72.2 years, 55% male. After adjust-
ing for age, sex and total brain volume, greater WMHv was associated with
poorer general cognitive ability (β = −0.008, p = 0.04), (processing speed 
(β = −0.009, p = 0.02) and visuospatial ability (β = −0.06, p = 0.008), but
not memory and executive/attention ability.The association between WMHv
and visuospatial ability was markedly attenuated (β = −0.04, p = 0.07) after
further adjusting for processing speed.
Conclusion: Greater WMHv is independently associated with poorer pro-
cessing speed, consistent with a disconnection syndrome. Its effects on speed
may largely explain its association with visuospatial function.
Concurrent 1 – Platform Session
Wednesday, 13 August 2008: 1515–1530 h
IS CT DUAL TARGET IMAGING A VALID BASIS FOR STROKE 
THROMBOLYSIS?
Aaron Tan, Kelly Coughlan, Janet Bray, Mark Parsons, Christopher
Bladin
Box Hill Hospital (Monash University) – Melbourne, VIC, John Hunter
Hospital – Newcastle, NSW
Background: In acute ischaemic stroke computed tomographic angiogra-
phy (CTA) is useful in the identification of intracranial vessel occlusion, and
computed tomographic perfusion (CTP) can be used to measure cerebral
perfusion.
Aim: To determine if the presence of both vessel occlusion on CTA and a
perfusion deficit on CTP (‘dual imaging target’) is a valid basis for selecting
patients for stroke thrombolysis.
Method: Retrospective review of patients receiving intravenous tissue plas-
minogen activator (tPA) who had both a pre-thrombolysis CTA and CTP
were analysed. The presence or absence of an intracranial occlusion and/or
perfusion deficit was noted and categorised as either CTA+CTP+, CTA−
CTP+, or CTA−CTP−. Outcome [modified Rankin Scale (mRS) and
National Institutes of Health Stroke Scale (NIHSS)] was measured at 3
months for each group. Patients with brainstem stroke, or ipsilateral extracra-
nial internal carotid artery occlusion, were excluded.
Results: 148 patients with a mean age of 71 years (43% female) were
included. Baseline median NIHSS was 14. Outcome at 3 months was
favourable (mRS 0–2) in 56% of patients. Patients with both intracranial
vessel occlusion and a perfusion deficit (CTA+/CTP+) had greater disability
(median NIHSS 18) at presentation compared with those with no occlu-
sion/no perfusion deficit (CTA−/CTP−) (median NIHSS 8). Favourable
outcome (mRS 0–2) at 3 months for the CTA+CTP+ group was 47%.
Conclusion: Patients with CTA+/CTP+ have more severe strokes but greater
potential benefit from thrombolysis. A CT dual imaging target may allow a
more select approach to the delivery of acute stroke therapies.
Concurrent 2
Concurrent 2 – Platform Session
Wednesday, 13 August 2008: 1400–1415 h
TAKING THE IVORY TOWER OF ACADEMIC RESEARCH INTO THE
CLINICAL WORLD: CLINICIANS’ EXPERIENCES OF PARTICIPATING IN
AN INTERNATIONAL REHABILITATION TRIAL (AVERT)
R Chen
AVERT Westmead, on behalf of the AVERT Collaboration, NSW
Background: In 2006,Westmead Hospital stroke unit became a trial site for
AVERT, a multi-centre, randomised trial of very early rehabilitation with a
focus on mobilisation.We participated:1) because of interest in the trial ques-
tion; 2) to test the feasibility of balancing a clinical caseload with research.
In this presentation, we describe the benefits, challenges and local solutions
to participating in a multi-centre clinical trial.
Participation Experience: Pre-trial activities required support from
AVERT management, the stroke unit director and nurse unit manager. Our
team developed procedures to ensure smooth running of the trial with clear
communication and quality data collection. As of April, 2008, we have
screened 225 patients and recruited 20 (9%). Maintaining commitment to
the study requires ongoing encouragement and performance feedback.
Benefits: Participation has enhanced communication between nursing and
medical staff in the emergency department and stroke unit. Strong collabo-
ration between staff has elevated the quality of service delivery and the trial
is running smoothly. Introducing staff to research has fostered greater inter-
est in evidence-based practice.
Challenges: The greatest challenge has been balancing clinical caseloads
with research. Completing paperwork on time takes organisation and com-
mitment. Complying with AVERT protocols as we integrate them into our
usual unit practice is a challenge in our comprehensive stroke unit.
Future Goals: We aim to double recruitment to two patients per month and
use trial funding to enhance education opportunities for all stroke unit staff.
Finally, we hope the experience of participating in the AVERT trial inspires
members of our unit to initiate other research projects.
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Concurrent 2 – Platform Session
Wednesday, 13 August 2008: 1415–1430 h
WHAT GOES ON IN REHABILITATION CASE CONFERENCES? A QUAL-
ITATIVE ANALYSIS
Alison Ferguson1, Linda Worrall2 & Sue Sherratt1
1University of Newcastle1, NSW; and 2University of Queensland, QLD
Background: What goes on in the rehabilitation case conference is of inter-
est from a clinical perspective regarding shared clinical decision-making, and
from a critical discourse perspective regarding how the discussion reflects
and creates the professional and institutional culture in which care is being
delivered.
Aims: The research aimed to investigate the collaborative contribution 
to clinical decision-making by health professionals in rehabilitation case 
conferences.
Methods: Detailed field notes were taken during a series of 6 consecutive
case conferences of a multidisciplinary stroke rehabilitation team. Confer-
ences lasted between 1–3 h, involving between 10–14 health professionals,
discussing between 7–10 inpatients per conference (13 patients in all – 7
CVA, 2 TBI, and 4 ‘other’). Subsequent analyses used a combination 
of apriori coding categories (based on the International Classification of
Functioning – WHO, 2001), and content and thematic analyses.
Results: As expected, the rank order of frequency of contribution reflected
both distinct and overlapping areas of professional areas of expertise and
responsibility. Further analyses indicated that moments which involved more
conflicting and transdisciplinary contributions were typically those that
occurred when discussing clients with impaired communication and/or cog-
nitive capacity. In comparison with other patients, for those with aphasia, the
discussion did not allude to patients’ own goals, and patients’ controlling
behaviours were discussed as problematic.
Discussion: Difficulties with cognition and communication present reha-
bilitation professionals with critical challenges for clinical decision-making.
The research provides a framework for reflecting on teamwork in managing
these challenges, and directions for further research.
Concurrent 2 – Platform Session
Wednesday, 13 August 2008: 1430–1445 h
VERY EARLY REHABILITATION AFTER STROKE MAY IMPROVE LONG-
TERM QUALITY OF LIFE
Karen Tyedin1, Toby Cumming2 & Julie Bernhardt2
1La Trobe University, Melbourne, VIC; and 2National Stroke Research
Institute, Melbourne, VIC
Background: The sudden onset of stroke can drastically change the physi-
cal, social and psychological facets of a person’s life. Commencing an early
rehabilitation programme (focussing on mobilisation) in the acute stages of
stroke may improve long-term quality of life.
Aims: To determine whether stroke patients who receive very early mobili-
sation (VEM) experience better long-term quality of life than patients receiv-
ing standard care (SC).
Methods: Data were collected in Phase II of A Very Early Rehabilitation Trial
(AVERT), a multi-centre randomised controlled trial. Patients in the VEM
group commenced physical activity earlier (within 24 h of stroke), and were
mobilised more frequently, than SC patients. The Assessment of Quality of
Life (AQoL) questionnaire was used to evaluate quality of life at 12 months
post-stroke.
Results: Data from 68 of the 71 Phase II participants were available at 12
months. Quantile regression and Mann–Whitney analyses were used on the
non-normal, non-linear AQoL data. Median AQoL score was higher in VEM
(0.32) than SC patients (0.24). Adjusting for age, sex and stroke severity
(NIHSS), regression indicated a group difference at the 75th percentile (P =
0.003), but not at the median or 25th percentile. No difference was found
using adjusted Mann–Whitney (P = 0.168). For the ‘independent living’
AQoL domain, Mann–Whitney revealed higher scores in VEM patients (P =
0.055), particularly after adjustment for age (P = 0.033) or stroke severity 
(P = 0.038).
Conclusion: Very early rehabilitation may have a positive effect on quality
of life at 12 months after stroke, particularly in the ‘independent living’
domain.These results need to be confirmed in a larger Phase III trial, which
is currently underway.
Concurrent 2 – Platform Session
Wednesday, 13 August 2008: 1445–1500 h
GATHERING THE EVIDENCE. THE USE OF AN ENRICHED ENVIRON-
MENT POST STROKE
Heidi Janssen1, Janice Collier2, Julie Bernhardt2, Michael Pollack1,3,
Emily Sena2, Neil Spratt1,3
1Hunter Stroke Service, NSW; 2National Stroke Research Institute; and
3University of Newcastle, NSW
Background: An enriched environment (EE) refers to conditions that facil-
itate enhanced sensory, cognitive and social stimulation. In animal stroke
models, a number of trials have studied the effect an EE has on outcome.
Examining these trials in animals could provide insights into the important
components of EEs, enabling translation into the clinical setting and guid-
ance of future study design in animals.
Aims: Conduct a systematic review to establish (i) study quality (ii) the effect
an EE has on adverse events, anatomical and neurobehavioural outcomes,
and (iii) the key components (timing, dose and types of stimulation) of EE
in animal stroke models.
Methods: A systematic review of electronic bibliographic databases, together
with manual searches of relevant reference lists and abstracts was performed.
Study quality was assessed against an established quality score. Outcomes
were mortality, neurobehavioural score and lesion size. Following extraction
of data, summary effect sizes and sensitivity analyses were performed.
Results: Of the 63 identified, 18 were reviews or abstracts and 23 were
excluded, leaving 22 studies (∼300 animals) for examination. Quality of trials
was low, with 27% randomised, 45% blinded and 27% excluding animals
retrospectively. Review also revealed heterogeneity of EE trials, with dose,
timing of intervention and types of stimulation the main variants.
Conclusions: Further investigation of EEs in animal stroke models is war-
ranted given the potential for new knowledge in this field to be relevant to
stroke rehabilitation in humans. We recommend that future trials aim to
improve upon trials of the past with particular attention to study design and
standardisation.
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DRIVING AFTER STROKE: IMPLICATIONS FOR INDEPENDENCE AND
PSYCHOLOGICAL MORBIDITY: PRELIMINARY FINDINGS FROM A
LONGITUDINAL QUALITATIVE STUDY OF COMMUNITY STROKE 
SURVIVORS
Jennifer White, Parker Magin, Michael Pollack
Hunter Stroke Service, NSW
Background: The consequences of stroke can be devastating to the stroke
survivor. Cessation of driving after stroke can markedly impact independence
and lifestyle. There is limited evidence relating to the long-term experience
of return to driving after stroke.
Aims: To longitudinally explore the experience of return to driving after
stroke.
Methods: A longitudinal, qualitative study using a modified grounded theory
approach. Participants (currently n = 10) were community-dwelling stroke
survivors in Newcastle, New South Wales, identified from a tertiary referral
hospital. In-depth, semi-structured interviews were conducted after discharge
from hospital (baseline), 3 and 6 months after stroke. Qualitative outcomes
were participants’ perceptions. Transcripts of interviews were subjected to
thematic analysis employing a modified grounded theory approach and using
a process of constant comparison.
Results: Preliminary themes are emerging from the data.These include: loss
of independence and impact on lifestyle, but also marked impact on self-
esteem and self-image. Findings relating to these themes will be discussed in
depth.
Discussion: Return to driving after stroke is of key importance to many
stroke survivors. Failure to return to driving has a profound impact on com-
munity mobility, and social participation. This can create significant psycho-
logical morbidity. Findings reinforce the need for interventions that support
the transitions home and grief surrounding role loss, such as driving.
Concurrent 2 – Platform Session
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FACTORS ASSOCIATED WITH RETURN TO DRIVING FOLLOWING
STROKE
Michelle Turnbull, Judy Ranka
The University of Sydney, NSW
Background
Driving is an important activity of daily living that can be severely impacted
by the sequelae of stroke and evidence suggests that more people cease
driving than resume driving following a stroke. The need for comprehensive
assessment of driving skills is well supported in the literature, although there
is little consensus on the most effective method of assessment.
Aim: The study aimed to investigate the prevalence of driving 3 months fol-
lowing stroke and determine what, if any, factors were associated with this
outcome.
Method: A prospective case series design was used. A sample of 20 partici-
pants was drawn from admissions to the stroke unit of a Sydney metropoli-
tan teaching hospital. Results: from assessments (Functional Independence
Measure, Mini-Mental Status Examination and Perceive, Recall, Plan,
Perform System of Task Analysis) were obtained at baseline (admission to
the study), discharge and at follow-up (3 months post discharge).These data
were then correlated with self-reported return to driving outcome at follow-
up.
Results: The prevalence of return to driving in the sample was 40% with
significant associations found between the variables of functional status, cog-
nitive status, and information processing impairment and the return to
driving outcome at 3 months post discharge.
Conclusion: While on road assessment continues to be seen as the ideal
method of determining fitness to drive, evidence suggests that alternate
methods are required.This study demonstrates the clinical utility of the FIM,
MMSE and PRPP in identifying factors associated with the return to driving
following stroke.
Concurrent 3
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EVIDENCE-BASED INPATIENT STROKE CARE AND CERTIFICATION OF
STROKE PROGRAMMES AS SPECIALIZED STROKE CENTRES/UNITS
Dawn M Meyer
Sharp Memorial Hospital, San Diego, CA, USA
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AMBULANCE ASSESSMENT AND TRIAGE
Jeffrey Saver
Geffen School of Medicine, UCLA, USA
THE USE OF TELEMEDICINE IN ACUTE ASSESSMENT AND 
THROMBOLYSIS
Timothy Ingall
Cerebrovascular Diseases Center, Mayo Clinic Arizona, Phoenix, AZ,
USA
In recent years, telemedicine, via either the telephone or a video link, has
been deployed in the care of acute stroke patients.While stroke telemedicine
has been adopted enthusiastically by some practitioners, there is scant data
regarding whether the evaluations help physicians to make appropriate man-
agement decisions or whether telemedicine outcomes match the outcomes
from care provided at stroke centres. Stroke telemedicine issues include:
1. Are video consults preferable to telephone consults?
2. How much education and training is needed at ‘spoke’ sites?
3. What is the legal liability of physicians providing telemedicine consults?
4. Who is responsible for providing acute stroke care after the telemedicine
consult is completed?
The Mayo Clinic Hospital in Phoenix, Arizona is participating in an acute
stroke telemedicine study comparing the effectiveness of telephone versus
video consults in evaluating acute stroke patients who present to two rural
Arizona hospitals in Yuma and Kingman. From 12/2007 through 5/2008, the
Stroke Telemedicine hotline has been activated 56 times and 32 patients have
been randomized to either a telephone or video consult. The stroke neurol-
ogists in Phoenix at the ‘hub’ hospital consult with ED physicians at the two
rural ‘spoke’ hospitals and recommend whether stroke patients are candi-
dates for treatment with intravenous tPA. The data from this study will be
combined with the data from a similar study conducted at UCSD in San
Diego, California in order to determine whether better care is provided by a
video consult compared with a telephone consult.
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DETECTION OF SMALL VESSEL KNOCK SIGNALS BY DOPPLER
ULTRASOUND IN A LABORATORY MODEL SIMULATING A PENE-
TRATING BRANCH OCCLUSION
Chesda Udommongkol1, Brian Chambers1, Richard Manasseh2, Ilija
Sutalo2, Ben Aldham2, Emma Chung3, Geoffrey Donnan1
1National Stroke Research Institute and the University of Melbourne,
VIC; 2Commonwealth Scientific and Industrial Research Organization;
and 3University Hospitals of Leicester, UK
Background: Small vessel knock (SVK) was recently reported as a new 
transcranial Doppler (TCD) sign of penetrating artery occlusion. However,
knock-like signals may be caused by wall motion of normal basal cerebral
arteries. Preliminary in vitro studies in Leicester suggest that SVK can be
recorded using TCD insonation of a side-branch lumen independent from
the vessel wall.
Aim: To demonstrate SVK in a laboratory model simulating a cerebral
branch occlusion.
Materials and Method: Our system consisted of a flow rig, peristaltic
pump, reservoir tank and water tank. The flow circuit was filled with blood
mimicking fluid (BMF) that contained physical and acoustic properties
similar to human blood. Flow and viscosity were controlled to conform to
normal human physiology. A scaled-up synthetic bifurcation was made from
silicone tubing with internal diameter 9.53 mm for the main artery and 2.38
mm for the side branch. It was submerged in the water tank and connected
to the flow rig. The smaller branch was insonated before and after occlusion
using a Compumedics Doppler Box with 2 MHz probe and Sonix RP Ultra-
sonix with 9–4 MHz probe.
Results: BMF recirculation in the blocked branch was detected by video
recording after dye injection and colour Doppler. Spectral Doppler demon-
strated corresponding continuous, bidirectional, low-frequency Doppler
signals. However, SVK was not observed.
Conclusion: In our in-vitro model, SVK was not detected by TCD and
duplex ultrasound. Factors that might explain these negative results include
angle of vessel bifurcation, flow pressure and tube material.
Concurrent 5 – New Investigator Award –
Session 2
Wednesday, 13 August 2008: 1615–1630 h
USEFULNESS OF HOLTER MONITORING, THROMBOPHILIA AND VAS-
CULITIS SCREENING TESTS IN THE INVESTIGATION OF A HET-
EROGENOUS GROUP OF ISCHAEMIC STROKE PATIENTS
Nerissa Jordan, Soumya Ghosh, John Cunningham, Anthony Alvaro
Stroke Unit, Dept. of Neurology, Fremantle Hospital, WA
Background: Ischaemic stroke patients are frequently investigated for
paroxysmal cardiac arrhythmia, underlying vasculitis and thrombophilic ten-
dency.The usefulness and cost-effectiveness of routinely investigating for the
above (using 24 h Holter monitoring and blood testing for thrombophilia and
vasculitic markers) is not clear.
Aims: To assess if Holter monitoring, thrombophilia screening and vasculi-
tis screening tests contributed significantly to the management of ischaemic
stroke patients.
Methods: We retrospectively evaluated consecutive cases of ischaemic stroke
admitted to the Fremantle Hospital Stroke Unit over 1 year (2007). Analy-
sis involved noting if Holter monitoring, thrombophilic screening or vascul-
tic screening was performed and if these investigations significantly altered
patient management. Tests were ordered at the discretion of the physician.
Documentation of stroke class (Oxfordshire Stroke Classification), demo-
graphic information and other investigations were also noted.
Results: One or more of the three screening tests were performed on a large
proportion of patients. Positive test results were rare and influenced man-
agement less often. The tests did not appear to be more useful for any par-
ticular ischaemic stroke class, younger stroke patients or those with
‘cryptogenic’ stroke.
Discussion: We found that in our group of patients with ischaemic stroke,
the yield of Holter monitoring, thrombophilic screeing and vascultic screen-
ing was low for identifying abnormalities which significantly altered patient
management. Given the costs involved, we advise against the routine use of
these tests, unless specifically indicated. The use of these tests in younger
stroke patients and in those with cryptogenic stroke requires further study.
Concurrent 5 – New Investigator Award –
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HOSPITAL ADMISSION OF TIA PATIENTS REDUCES RECURRENT
EVENT RATE ACROSS ALL ABCD2 SCORES
Darshan Ghia, Dennis Cordato, Peter Thomas, John Worthington, 
Alan McDougall, Ibrahim Hanna, Neil Griffith, Cecilia Cappelen-Smith,
Roy Beran, Suzanne J Hodgkinson, Jasveen Chadha
Department of Neurology, Liverpool Hospital, NSW
Aim: To determine whether moderate to high ABCD2 score (≥4) is associ-
ated with increased risk of stroke or TIA recurrence at 3 and 12 months, in
patients presenting with ED diagnosis of TIA.
Methods: All patients with ED diagnosis of TIA (ICD-9-CM) between
January 2004 and December 2006 were identified to determine ABCD2
scores and final diagnosis (TIA, stroke and ‘other’). All presentations were
matched by ‘person-identifier’ to capture all regional re-presentations within
12-month. Three-month and 1-year stroke or TIA event recurrence for
patients with moderate to high ABCD2 score was compared with patients
with low ABCD2 score.
Results: There were 324 ED presentations of TIA (286 admissions and 38
discharges from ED). 184 patients had final diagnosis of TIA, 65 had stroke,
and 75 had ‘other’ diagnoses. 229 patients had moderate to high ABCD2
score. Patients with ‘other’ diagnoses had low ABCD2 score compared with
patients with TIA (p < 0.0001) or stroke (p < 0.0001). At 3 months, 2 patients
(2.1%) with low ABCD2 score had TIA recurrence compared with 7 patients
(3.1%) with moderate to high ABCD2 score (p > 0.05). At 12 months, 5
patients (5.3%) with low ABCD2 score had TIA recurrence compared with
11 patients (4.8%) with moderate to high ABCD2 score (p > 0.05). 1 patient
with ‘other’ diagnosis had TIA recurrence between 3 and 12 months.
Conclusions: There was low 3-month stroke or TIA event recurrence for
patients with both low and moderate to high ABCD2 scores.This may reflect
reduced risk of event recurrence due to hospital admission with rapid com-
prehensive management of TIA.
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IS FAST STROKE SMART: DOES THE LANGUAGE USED IN PUBLIC
EDUCATION CAMPAIGNS DESCRIBE THE EXPERIENCE OF STROKE
SYMPTOMS?
Janet Bray1,2, Bev O’Connell2, Melissa Wright1, Amanda Gilligan1, 
Chris Bladin1,3
Box Hill Hospital1, Deakin University2, Monash University3
Introduction: There are few published reviews of public stroke education
campaigns.This study compares presenting symptoms as described by stroke
patients and witnesses to those utilized in the ‘FAST’ (face, arm weakness
and speech) and ‘Signs of Stroke’ campaign used by the National Stroke
Foundation of Australia.
Methods: Interviews were conducted with either the stroke patient or a
witness to the acute stroke event while an inpatient at Box Hill or Maroon-
dah Hospitals from August 2006 through March 2008. They were asked to
describe symptoms and to evaluate the descriptions of ‘Signs of Stroke’
against their own experience.
Results: A total of 95 inpatients and 51 witnesses were interviewed. Few
patients (n = 11) and witnesses (n = 4) were aware of the FAST campaign
(posters, advertisements and emails). At least one FAST symptom was
described by 69 (73%) patients and 48 (94%) witnesses. Patients not describ-
ing a FAST symptom (n = 26) described arm or hand numbness (n = 10)
and/or incoordination (n = 7), or vision disturbance (n = 8). Among patients
the most common ‘Signs of Stroke’ was ‘weakness or paralysis of an arm or
leg’ (76%). However, only 44% thought this description exactly described
their experience. Witnesses commonly described a change in speech (90%),
and 70% rated ‘difficulty speaking’ as exactly describing the experience.
Common descriptions of symptoms were: ‘dropped’ face; ‘slurred’ or loss 
of speech; ‘numbness’, ‘tingling’ or ‘heaviness’. Motor symptoms were
described by altered patient functioning: coordination/control, mobility and
balance/falls.
Conclusion: The wording of the FAST and ‘Signs of Stroke’ campaign could
be improved by using words that are commonly used by the public to describe
their symptoms without impacting on the simplicity of the messages.
Concurrent 5 – New Investigator Award –
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FACTORS ASSOCIATED WITH SYMPTOMS OF DEPRESSION AT 5
YEARS AFTER STROKE IN THE NORTH EAST MELBOURNE STROKE
INCIDENCE STUDY (NEMESIS)
Seana L Paul1,2, Helen Dewey2, Amanda Thrift3
1Menzies Research Institute, Hobart, TAS; 2National Stroke Research
Institute, Melbourne, VIC; and 3Baker Heart Research Institute, Mel-
bourne, VIC
Background & Aim: There are few studies of the factors associated with
symptoms of depression after stroke. We aimed to identify the sociodemo-
graphic, stroke outcome and vascular risk factors associated with depression
scale scores among 5-year stroke survivors.
Methods: Stroke survivors from an ‘ideal’ stroke incidence study were inter-
viewed. We collected baseline data on demographics and stroke severity
(National Institutes of Health Stroke Scale), and concurrent data on dis-
ability (Barthel Index), hypertension (diastolic blood pressure ≥ 90mmHg
and/or systolic blood pressure ≥ 140mmHg and/or taking antihypertensive
agents), smoking (never, former, current), alcohol consumption (g/week) and
physical activity (sessions/week). The depression subscale of the Irritability,
Depression and Anxiety Scale (score range: 0–15; greater scores denote
greater disease) was administered to self-responders. Analyses were con-
ducted using linear regression.
Results: 377 of 441 5-year survivors responded for themselves and 289
(77%) had depression data. Those not assessed were more often born over-
seas than those assessed (p = 0.007).The mean depression score was 3.9 (SD
2.8). After adjusting for sex, age, occupation and initial stroke severity, factors
positively associated with depression scores were current smoking (β = 0.26,
p = 0.04), being disabled (β = 0.54, p < 0.0001), and hypertension (β = 0.20,
p = 0.04); physical activity ≥3 times per week was negatively associated with
depressions scores (β = −0.23, p = 0.03).
Conclusion: Disability and hypertension, independent of age and sex, were
associated with more symptoms of depression.The association between phys-
ical activity and depression symptoms, which was independent of age, sex
and disability, may suggest a non-pharmacological pathway to alleviate post
stroke depression.
Concurrent 5 – New Investigator Award –
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IS AN ORGANISED AND MULTIDISCIPLINARY PROGRAMME TO
IMPROVE BLOOD PRESSURE CONTROL TO PREVENT STROKE IN
AUSTRALIA WORTHWHILE?
Dominique A Cadilhac1, Robert C Carter2, Amanda G Thrift3, 
Helen M Dewey1
1National Stroke Research Institute, Heidelberg Heights, VIC; 2Deakin
University, Burwood, VIC; and 3The Baker Heart Research Institute, Pra-
haran, VIC
Background: The most important modifiable risk factor for stroke is high
blood pressure (BP). However, 60% of Australians receiving treatment for
high BP are uncontrolled.
Aim: To assess whether a programme of organised multidisciplinary care
with regular follow-up and medication would be cost-effective for improving
BP control as both primary and secondary prevention of stroke in Australia.
Methods: The interventions were designed to conform with current
enhanced primary care Medicare items. The incremental difference between
current practice and the intervention was assessed as the net cost per Quality
Adjusted Life Year (QALY) gained. Cost-effectiveness was defined as a
cost/QALY gained of <$50,000 (societal perspective). Reference year: 2004.
Incident cases of stroke prevented contributed lifetime benefits and cost-offsets.
Recurrent stroke cost-offsets were counted for only 1 year. Multivariate
uncertainty analysis (6,000 simulations) was used to assess the robustness of
estimates.
Results: Organised care was cost-effective for ‘high risk’ populations. For
primary prevention, in hypertensive people aged 75+, the median cost/QALY
gained was $11,068 (95% uncertainty interval [UI] $5,201 to $18,696),
while in those aged 55–84 years with a ≥15% ‘absolute risk’ of stroke the
median cost/QALY gained was $17,359 (95% UI $10,516 to $26,036). The
median cost/QALY gained for secondary prevention was between $1,811 and
$4,704 given different medications used. Primary prevention interventions
for people aged below 50 years were not cost-effective.
Conclusions: Organised care for BP control targeted at specific ‘high risk’
populations offer excellent value over current practice. Available Medicare
items should facilitate improved translation into clinical practice.
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ARM FUNCTION, FMRI AND EARLY REORGANISATION MAPPING IN
STROKE [AFFERMS]: FINDINGS FROM THE PILOT PHASE
Isobel Hubbard, Bill Budd, Mark Parsons
Neurology, Acute Stroke, Allied Health, John Hunter Hospital, NSW
Background: Strokes often result in adverse outcomes in upper limb func-
tion, which in turn, adversely affects participation in everyday activities. An
improved understanding of changes in brain activation patterns and its cor-
relation with upper limb motor recovery is potentially available using func-
tional magnetic resonance imaging (fMRI). This study is imaging brain
activation patterns in response to a finger-tapping task and measuring post-
stroke changes in the first 3 months. The pilot phase of data collection has
been completed.
Method: AFfERMS is a prospective, randomised controlled trial of patients
diagnosed with an ischemic hemispheric infarction in the previous week,
which resulted in upper limb weakness. Suitable patients consenting to the
study were randomised 1:1 to self-directed/conventional upper limb therapy
and increased face-to-face upper limb therapy. Outcome measures were
recorded at baseline, at 1 month post stroke/intervention and at 3 months
post stroke.The measures included fMRI, upper limb functional assessments
and stroke impact scales.
Results: The study has completed its pilot phase and findings indicate the
following trends: (i) Improved upper limb function for those in the inter-
vention group, (ii) Reduced contralesional activation in those that experi-
enced ‘good’ recovery, and (iii) Differences in post stroke recovery patterns
between the cortical and subcortical cohorts.
Conclusion: Initial findings indicate that the changes in brain activation pat-
terns immediately following a stroke event may correlate with differences in
post stroke management and stroke sub-type, and these changes are still
evident at 3 months post stroke.
Concurrent 6 – Platform Session
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NEW CLINICAL INDICATORS FOR ACUTE STROKE MANAGEMENT
Dawn Harris1, Dominique A Cadilhac2; On behalf of the National Stroke
Foundation Advisory Committee: National Stroke Audit Acute Services
and the National Stroke Audit Collaborative
1National Stroke Foundation, Melbourne, VIC; and 2National Stroke
Research Institute, Heidelberg Heights, VIC
Background: Clinical indicators provide a mechanism by which clinicians
are able to monitor and improve the quality of care. The 2002 national clin-
ical indicator set for stroke predates the updated Clinical Guidelines for
Acute Stroke Management (2007).There is a need to ensure the clinical indi-
cator set is consistent with current practice recommendations so that clini-
cians may use this indicator set in a meaningful and continuous way.
Aim: To revise the national clinical indicators for acute stroke management
to be consistent with current evidence based care.
Methods: Indicators from the 2007 National Stroke Audit were subjected
to value-based judgements by members of the National Advisory Commit-
tee using four criteria (level of evidence; clinical relevance; consumer impor-
tance; international comparability) as well as statistical analyses using two
independent methods. The results of each process were compared to finalise
the indicator subset.
Results: The final selected set comprised 14 indicators.These indicators rep-
resented care across all phases of acute care including early interventions,
assessment by allied health and discharge planning processes. Four indica-
tors were consistently selected irrespective of method (expert judgment or
statistical methods). These were: stroke unit care, and provision, within 48
h, of aspirin, physiotherapy assessment and speech pathology assessment.
Discussion: The National Stroke Audit provides a biennial opportunity to
examine all aspects of stroke care. The new subset of clinical indicators pro-
vides a tool by which quality of care may be monitored. These contempo-
rary, evidence based indicators may facilitate longitudinal comparisons and
permit improvements in key aspects of care.
Concurrent 6 – Platform Session
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SECONDARY PREVENTION IN ACUTE STROKE MANAGEMENT:
AUDIT RESULTS
Dawn Harris1, Graeme Hankey2; On behalf of the National Stroke Foun-
dation Advisory Committee: National Stroke Audit Acute Services and
the National Stroke Audit Collaborative
1National Stroke Foundation, Melbourne, VIC; and 2Royal Perth Hospi-
tal, Perth, WA
Background: Three significant pharmacological interventions should be
provided post stroke: treatment with lipid-lowering and antithrombotic med-
ication for all patients with ischaemic stroke, and treatment with antihyper-
tensive therapy for all stroke types. The type of medication used may vary,
and in some cases the evidence supports one agent over another.
Aim: To examine the secondary prevention strategies employed on discharge
for acute stroke patients using national audit data.
Methods: 89 hospitals were recruited to participate in a national clinical
audit of acute stroke management. Clinicians at participating sites conducted
a retrospective audit of 40 patient case notes admitted between 1 October
2006 and 31 March 2007.
Results: In total 2,724 case notes were audited. 1,739 (74%) of the 
2359 patients eligible for antihypertensive treatment on discharge received
this treatment with the majority (76%) discharged on an ACE-inhibitor/
Angiotensin II. Of the 1763 patients with ischaemic stroke discharged alive
1090 (62%) were discharged on lipid-lowering therapy with the majority
(98%) discharged on a statin. Only 1066 (61%) of ischaemic stroke patients
were discharged on aspirin and 256 (15%) patients were discharged on
dipyridamole. There had been no reason indicated in 71 (44%) of the 162
patients that had been discharged without antithrombotic therapy.
Discussion: Analysis of the audit data has demonstrated how treatment with
pharmacological therapy is provided in Australia. Despite evidence-based
recommendations on the use of particular classes of pharmacological agents
over others when considering anti-platelet therapy (Clinical Guidelines for
Acute Stroke Management 2007) adherence to these recommendations is
quite low.
Concurrent 6
© 2008 Royal Australasian College of Physicians A81
Internal Medicine Journal 2008; 38 (Suppl. 4): A71–A118
Concurrent 6 – Platform Session
Wednesday, 13 August 2008: 1645–1700 h
CONTINENCE MANAGEMENT IN ACUTE STROKE: A SURVEY OF
CURRENT NATIONAL PRACTICES
Louise Jordan1, Mary Wyer2, Elizabeth Mackey3, Kelly Couglan3, 
Cate Ferry4, Sandy Middleton4
1Hunter Stroke Service, Hunter New England Health, NSW; 2Formerly,
St Vincent’s Hospital, South Eastern Sydney Illawarra Health, NSW;
3Box Hill Hospital, Eastern Health, VIC; and4National Centre for Clinical
Outcomes Research (NaCCOR), Nursing & Midwifery, Australia, ACU
National
Background: Urinary incontinence (UI) is a common consequence post-
stroke and is the most significant indicator of poor outcome including dis-
ability and admission to institutional care. The National Stroke Foundation
(NSF) have produced guidelines for both the acute and post-acute phase of
care that offer nurses evidenced based recommendations regarding stroke
management including the management of UI.
Aim: To determine current national UI management practices in Australian
acute stroke units (ASUs) and their concordance with the NSF guidelines.
Method: Dedicated ASUs in NSW were identified by Stroke Services NSW.
ASUs in other states were identified as listed on the National Stroke Foun-
dation’s website. A senior nurse from each ASU was asked to participate in
our 10-min telephone survey.
Results: Forty nurses representing 40 ASUs from six states participated.
Almost half of the nurses (n = 18, 45%) reported their ASU had a written
formal UI management plan. In 11 of these units (61%), the nurses stated
it was ‘highly likely’ or ‘likely’ that the plan would be implemented for all
ASU patients.The minority of the 40 ASUs (n = 12, 30%) managed urinary
retention with intermittent catheterisation. Almost half the nurses (n = 18,
45%) were ‘very dissatisfied’ or ‘dissatisfied’ with the UI management of
patients in their ASU.
Conclusion: A large proportion of ASUs were yet to establish formal UI
management plans. Contrary to NSF guidelines, less then a third of ASUs
used intermittent catheterisation to manage urinary retention. Dissatisfac-
tion with UI management was reported. UI management for acute stroke
patients appears to be sub-optimal and the implementation of evidence-based
post-stroke UI management plans are warranted.
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ESTABLISHING COGNITIVE FUNCTION AFTER STROKE: CAN THE NIH
STROKE SCALE BE USED?
Thomas Linden1,2, Toby Cumming2, Christian Blomstrand1, 
Julie Bernhardt2
1Institute of Neuroscience & Physiology, University of Gothenburg,
Sweden; and 2National Stroke Research Institute, Melbourne, VIC
Background: Cognitive impairments are common after stroke, and have
dramatic effects on rehabilitation outcome. Disappointingly, even the short-
est available screening assessments, such as the Mini-Mental Status Exami-
nation (MMSE), are not routinely included in stroke studies. The NIH
Stroke Scale (NIHSS), in contrast, is common.
Aim: To investigate whether items in the NIHSS can indicate overall cog-
nitive status in groups of stroke patients.
Methods: We used data from 249 patients to develop an ultra-short cogni-
tive assessment method, based on items from the NIHSS: (1) the patient’s
awareness of the current month and (2) his/her own age, (3) ability to follow
a two-step command, (4) the assessor’s impression of language disturbance
and (5) attention deficit. Step-wise evaluation yielded a basic cognitive
impairment score. The model was validated against MMSE scores and clin-
ical diagnoses of cognitive impairment and DSM-III-R dementia.
Results: The score correctly identified 72% of the cognitively impaired
patients and 82% of the non-cognitively impaired. The inter-instrumental
agreement was moderate to substantial (kappa = 0.54, p < 0.0001).The area
under the receiver-operator curve was 0.80 (0.84 for the MMSE).
Conclusion: The composite cognitive score from the NIHSS classified
patients on cognitive impairment almost as well as the MMSE, raising the
possibility of quantifying cognitive function in studies without a dedicated
cognitive assessment. This is not, however, and nor is the MMSE, a method
of choice for detecting cognitive impairment in stroke populations, nor
should it be used for assessing cognitive function in individual patients.
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URINARY INCONTINENCE AFTER FIRST-EVER STROKE – 
PREVALENCE, TRANSITIONS AND PREDICTORS
Maree Williams1, Amanda Thrift2, Margaret Bird3, Velandai Srikanth1
1Monash Medical Centre; 2Baker Heart Research Institute; and 3Austin
Health, Melbourne, VIC
Background: There are few data on the natural history of Urinary Inconti-
nence (UI) in the medium to long-term after stroke in population-based
samples.
Aims: The aims of this project were to study the prevalence and natural
history of UI, and the factors that predict UI status at 12 months after a first-
ever stroke in a population-based sample.
Methods: Patients were recruited into the North East Melbourne Stroke
Incidence Study (NEMESIS). Data on urinary symptoms were collected at
3 and 12 months after stroke using a standardized Urinary Symptom Ques-
tionnaire. The prevalence proportions for UI were calculated at 3 months
and 12 month after stroke. Transitions in UI status were examined between
3 and 12 months. Baseline predictors of UI at 12 months were identified
using logistic regression.
Results: The response proportion for the UI questionnaire was 30%
(299/910 stroke survivors) at 3 months. Among responders, the proportion
of patients with new-onset UI was 32% at 3 months and 28% at 12 months.
Incontinence tended to persisit with recovery occurring in only 10% at 12
months. Pre-stroke UI (P < 0.001), female sex (P < 0.001), age (P < 0.001)
and greater stroke severity (P = 0.008) were associated with UI at 12 months
after stroke.
Discussion: UI is extremely common after first-ever stroke and tends to
persist at 12 months. Predictors of UI at 12 months were consistent with
those described previously in the literature. Although responders and non-
responders were similar in age, sex and stroke severity, the results may not
be generalisable to all first-ever stroke patients.
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Wednesday, 13 August 2008: 1600–1615 h
ECONOMIC HARDSHIP FROM STROKE IN CHINA
E Heeley1, Y Huang2, J Wang3, M Liu4, S Jian1, S Jan1, CS Anderson1
for the ChinaQUEST Investigators
1The George Institute for International Health, Sydney, NSW; 2Peking
University First Hospital, Beijing, China; 3Rui Jin Hospital, Shanghai,
China; and 4West China Hospital, Sichuan University, Chengdu, China
Background and Aims: Limited data exist on the household economic
impact of stroke in developing countries such as China, which largely still
have fee-for-service healthcare systems and limited health insurance schemes.
Methods: ChinaQUEST (QUality Evaluation of Stroke care and Treatment)
was a 62 hospital (36 city) register of all patients with acute ischaemic or
haemorrhagic stroke presenting over 5 months from 1 July 2006. Outcome
data (at hospital discharge and at 3 and 12 months of follow-up) were col-
lected by site investigators, entered onto a secure remote web-based system,
monitored for quality, both centrally and from site visits.
Results: Of the 6416 patients registered at baseline, 5446 (85%) were avail-
able for interview at 12 months and 1048 (20%) reported economic hard-
ship from stroke. Economic hardship was defined as being ‘unable to pay
utilities or living costs’, or having to ‘borrow money’ (generally from family
members, 94%) to meet out-of-pocket medical expenses. A significantly
higher proportion of patients with economic hardship were disabled at the
time of hospital discharge (47% vs 32%, p < 0.01), from manual occupations
(52% vs 48%, p < 0.01) and poorer regions (lower GDP) (63% vs 58%, p
< 0.01), and did not have any health insurance cover (42% vs 38%, p < 0.05).
Conclusions: In China, families appear to be under considerable economic
hardship following an acute stroke. The findings further highlight the great
importance of accelerating the ongoing process of building a comprehensive
healthcare system in both urban and rural China.
Concurrent 7 – Platform Session
Wednesday, 13 August 2008: 1615–1630 h
DO NATIONAL HOSPITALISATION AND MORTALITY DATA PROVIDE
EVIDENCE FOR AN EPIDEMIC OF STROKE IN AUSTRALIA?
Amanda Thrift1, Bin Tong2, Susana Senes2, Erin Lalor3
1Baker Heart Research Institute; 2Australian Institute of Health and
Welfare; and 3National Stroke Foundation
Background: There is major concern that Australia will experience an epi-
demic of stroke in coming years. This is based on the fact that Australia’s
population is ageing and stroke incidence increases with age.
Aim: To assess whether there is evidence that deaths and hospitalisations
from stroke in Australia are increasing.
Methods: We used nationwide age- and sex-specific hospitalisation episode
data from the 1996–1997 financial year to predict future hospitalisations
from stroke. Age- and sex-specific mortality data from 1997 were used to
predict future mortality from stroke.These predictions were based on demo-
graphic changes to the population, i.e. an increase in the population’s age
and population growth.We compared these estimates with those figures actu-
ally observed in the national figures for the following 8 (mortality) and 9
years (hospitalisations).
Results: Based on 1996–1997 hospitalisation rates we calculated that hos-
pitalisations for stroke would be expected to rise from 27,683 to 35,931 in
2005–2006. Using 1997 mortality rates we calculated that deaths from stroke
would be expected to rise from 12,403 to 16,537 in 2005. Observed hospi-
talisations (2005–2006) were 6,801 fewer than expected, while deaths (2005)
were 5,024 fewer than expected.This represents a 2.3% annual reduction in
hospitalisation rate, and a 4.5% annual reduction in mortality rate.
Discussion: Hospitalisations and deaths from stroke have not increased as
expected. Encouragingly, hospitalisation and mortality rates for stroke appear
to be declining. If these figures reflect actual occurrences of stroke then it
may be that primary and secondary prevention strategies are working.
Concurrent 7 – Platform Session
Wednesday, 13 August 2008: 1630–1645 h
PREHOSPITAL EPIDEMIOLOGY OF SUSPECTED STROKE PATIENTS IN
NSW
Romesh Markus1,2, Paul Middleton3,4, Sowmya Anand1,3, Mark Long-
worth1, Mary-Louise McLaws3, Julie Newman2, Judy Simpson4
1Greater Metropolitan Clinical Taskforce Stroke Network, NSW; 2St
Vincent’s Hospital, Sydney, NSW; 3Ambulance Service of NSW, NSW;
4School of Public Health and Community Medicine, University of NSW,
NSW; and 5School of Public Health, University of Sydney, NSW
Background: Outcomes for some stroke patients depend largely on prompt
recognition of stroke and shorter transport times by ambulance services.
Effective delivery of care for stroke patients therefore mandates attention to
pre-hospital recognition and management.
Aims: To investigate differences in ambulance performance time intervals
for stroke patients in rural and metropolitan areas, the proportion of 
suspected stroke patients within metropolitan Sydney taken to an acute
stroke unit, and diagnostic agreement between call takers and ambulance
paramedics.
Methods: Data for July 2004 to June 2007 were collected from Medical Pri-
ority Dispatch System (MPDS) and Patient Health care Record (PHCR)
databases. Median times were compared between metropolitan, rural, and
Priority 1 and 2 classifications.
Results: 35,313 patients had a diagnosis of stroke by either MPDS or PHCR
criteria, 24,161 (68.4%) in metropolitan and 11,152 (31.6%) in rural areas.
Of these, 20,997 (59.4%) patients were attended to following 000 calls, of
whom 8,841 (42.1%) were classified by MPDS as Priority 1 and 12,156
(57.9%) priority 2. Agreement between call takers and ambulance para-
medics was 36.6%.
Case Cycle Times were 19 min longer in metropolitan areas largely due
to longer Off-Stretcher Times (P < 0.0001). In metropolitan areas, 81.9% of
Priority 1 and 81.8% of Priority 2 patients were appropriately taken to a spe-
cialist stroke unit. However, the time from ambulance dispatch to transfer to
a metropolitan ED bed is on average 20 min longer than in rural areas due
to increased Off-Stretcher times.
Conclusion: Improvements in Off-Stretcher Time would positively impact
the outcomes of 6055 priority 1 patients in metropolitan areas. Improvement
in the positive predictive value of MPDS software may similarly benefit all
stroke patients.
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ACCESS AND ORGANISATION OF SERVICES FOR PATIENTS WITH TIA
ACROSS AUSTRALIA: DOES IT MEET BEST PRACTICE?
Chris Price1, David Blacker, Chris Bladin, Susan Day, Sonia Denisenko,
Helen Dewey, Richard Gerraty, Rohan Grimley, Peter Hand, Kelvin Hill,
Simon Koblar, Erin Lalor, Jane Levy, Mark Longworth, Catherine
Storey, Alistair Wright, Victorian Stroke Clinical Network Committee
(TIA subcommittee).
1National Stroke Foundation
Background: Hospitals reporting the presence of a specialist Transient
Ischaemic Attack (TIA) clinic in the National Stroke Audit dropped from 40
in 2004 to 27 in 2007 (11% of sites surveyed). New evidence confirms TIA
services need to be organised to provide rapid reponse in an equitable
manner.
Aim: To understand the current processes of care and management for
people with TIA to inform decision making regarding best practice models
of care.
Methods: A 27 question survey was created with input from a number of
key clinical leaders. Topics included organisation of services, assessment,
early management and follow-up.The survey went to over 130 hospitals that
had previously participated in the National Stroke Audit (2007). The results
were collated and analysed.
Results: While the survey was ongoing at the time of abstract submission,
preliminary findings confirm TIA clinics are not available in over 70% of
sites. Patients consistently arrived via emergency departments, however, the
pathway of care varied across settings. At the initial assessment the majority
of patients had routine bloods, CT and carotid investigation results within 4
h. MRI occurs in <10% of patients. Risk assessment, most commonly via
ABCD2 tool, is undertaken in >60% of patients. However, treatment is com-
menced within 48 h in just over 50% of cases and >70% of all sites intend
to review their service with a view to make changes.
Discussion: A variety of models and practices for TIA management is cur-
rently occurring across Australia. Full results and analysis will be discussed.
Concurrent 7 – Platform Session
Wednesday, 13 August 2008: 1700–1715 h
PATTERNS OF CARE AND MORTALITY OF INTRACEREBRAL HAEM-
ORRHAGE (ICH) IN A LARGE, REPRESENTATIVE AUSTRALIAN POPU-
LATION: ANALYSIS OF LINKED HOSPITAL AND MORTALITY DATA
Robert Aitken, John Worthington, Melina Gattellari, Bin Jalaludin
Centre for Research, Evidence Management and Surveillance, Sydney
South West Area Health Service, Department of Neurophysiology,
Sydney South West Area Health Service, School of Public Health and
Community Medicine, The University of New South Wales
Abstract not to be published
Concurrent 7 – Platform Session
Wednesday, 13 August 2008: 1715–1730 h
PATTERNS OF CARE AND MORTALITY OF SUBARACHNOID HAEM-
ORRHAGE (SAH) IN A LARGE, REPRESENTATIVE AUSTRALIAN POP-
ULATION: AN ANALYSIS OF LINKED HOSPITAL AND MORTALITY
DATA
John Worthington, Melina Gattellari, Robert Aitken, Bin Jalaludin
Centre for Research, Evidence Management and Surveillance, Sydney
South West Area Health Service and School of Public Health and Com-
munity Medicine, The University of New South Wales.
Abstract not to be published
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Wednesday, 13 August 2008: 1600–1730 h
IMPLEMENTING STROKE RESEARCH EVIDENCE
Annie McCluskey1, John Cannell2, Sandy Middleton3, Coralie English4,
Lorinda Upton-Greer5, Angela Vratsistas6
1National Institute of Clinical Studies-HCF Foundation Fellow; Senior
Lecturer (Occupational Therapy), The University of Sydney and occu-
pational therapy private practitioner, NSW; 2National Institute of Clini-
cal Studies Fellow & Physiotherapy Supervisor, Launceston General
Hospital, TAS; 3Director, National Center for Clinical Outcomes
Research (NaCCOR), Nursing and Midwifery, Australia & Australian
Catholic University, NSW; 4Lecturer, University of South Australia and
physiotherapy private practitioner, SA; 5Clinical Nurse Consultant,
Stroke Unit, Launceston General Hospital, TAS; and 6Team Coordina-
tor and Occupational Therapist, Transitional Aged Care Program, Bank-
town-Lidcombe Hospital, Sydney, NSW
Background: Published research about treatment effectiveness is not always
implemented in practice, even when recommended in clinical guidelines.
Reasons for low uptake include lack of team readiness for change, not being
aware of the evidence, not knowing what to do or how to do it. Evidence-
practice gaps result.
Workshop Aims:Our primary aim is to help practitioners and managers learn
how to implement interventions described in clinical guidelines, systematic
reviews and randomised controlled trials with individual patients and across
services.We will demonstrate how evidence-practice gaps can be identified and
overcome in acute stroke units, rehabilitation and community settings.
Learning Objectives: Participants will learn how to prepare an implemen-
tation plan, identify then target barriers to implementation.
Workshop Plan: Our programmes involve nursing practitioners, occupa-
tional therapists, physiotherapists and therapy assistants. Examples will
include (a) Optimising upper limb recovery in hospital settings using elec-
trical stimulation and task-specific practice; (b) Using group circuit class
therapy to increase task-specific practice (mobility and upper limb therapy);
and (c) Increasing outdoor journeys and community travel. Content will
include:
• Examples of evidence-practice gaps and how these are being targeted by
teams
• The implementation process
• Expected outcomes for professionals and teams (e.g. % of patients receiv-
ing the intervention) and patient outcomes (e.g. amount of practice con-
ducted)
• Barriers to implementation, as well as enablers/incentives
• Determining whether your organisation is ready for change
• Strategies to overcome barriers (e.g. audit/feedback, education, reminders)
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Thursday, 14 August 2008: 1000–1030 h
WHAT’S NEXT FOR THE ISCHAEMIC PENUMBRA: LIFE AFTER EPITHET
GA Donnan
National Stroke Research Institute, Austin Health, University of Mel-
bourne, VIC
There is a great need to increase the number of patients eligible for throm-
bolysis. This can either be achieved by increasing the number of patients
treated within the current 3-h time limit or providing level 1 evidence of effi-
cacy beyond this.
The phase II EPITHET trial has now been completed and while not reach-
ing statistical significance on the primary outcome measure of infarct growth
seen on MR, there were enough biological signals for the efficacy of tPA in
a trend for growth and a strongly positive secondary outcome measure for
reperfusion. The time window for this study was 3–6 h.
There is now a need to move the concept of patients selected by imaging
parameters for the presence of penumbra to conduct a phase III study with
the primary outcome measure functional clinical recovery. Based on the
EPITHET 3–6 h data, the sample size required for such a study would be
about 400 patients with 200 in the treatment arm.
We plan the EXtending the time for Thrombolysis in Emergency Neuro-
logical Deficits (EXTEND) phase III study in which patients will be selected
based on the presence of penumbra on MR imaging and a time window of
3–9 h.
Concurrent 10
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Thursday, 14 August 2008: 1005–1050 h
‘NEW TECHNOLOGIES USING FES IN NEURO REHABILITATION’ –
USING THE NESS L300 FOOT DROP STIMULATION SYSTEM TO
REGAIN LOST MOBILITY AND RECAPTURE A MORE NORMAL GAIT
Keith McBride
Director of Clinical Support and Education, Bioness
Foot drop is a common impairment impacting many persons following
stroke, brain injury, multiple sclerosis, and incomplete spinal cord injury.The
current standard for treatment of foot drop is the ankle foot orthosis (AFO).
The NESS L300 is an advanced neuroprosthesis designed to enable a more
natural gait by delivering electrical impulses to the Common Peroneal Nerve
which controls the movement of the muscles that cause the foot to dorsiflex.
The stimulation is delivered in a programmable sequence to assist in toe
clearance during swing and provide ankle and potentially knee stability
during loading. The wireless technology can be customized to fit a variety of
patient presentations as well as utilize real time algorithms to adapt to chang-
ing surfaces, conditions, and walking speeds.The stimulation cuff houses the
patient specific electrode placement and contains a unique fitting ‘locator’ to
assure reproducible stimulation response. The system is capable of tracking
patient usage through a gait and training log feature. The control unit pro-
vides precise control of stimulation intensity and mode as well as audio feed-
back and additional features for use in the clinic. The system is customarily
fitted by a physical therapist or orthotist and then patients receive follow-up
therapy by a physical therapy clinic. Evolving evidence supports the L300 to
improve walking speed, symmetry, stability, as well as outperform an AFO
in selected patients.
Concurrent 11
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Thursday, 14 August 2008: 1100–1115 h
FUNCTIONAL OUTCOME AFTER STROKE REHABILITATION: COM-
PARISON OF CEREBRAL INFARCTION AND INTRACEREBRAL 
HAEMORRHAGE
Pesi Katrak, Victoria Peeva
Prince of Wales Hospital, Sydney, NSW
Objective: To compare functional outcome following in-patient rehabilita-
tion in stroke patients with cerebral infarction (CI) and intra-cerebral haem-
orrhage (ICH). Data from previous studies examining CI and ICH outcomes
have produced conflicting results1,2.
Method: Analysis of data from a prospectively maintained database of all
stroke rehabilitation admissions to Prince Henry/Prince of Wales Hospitals,
Sydney, NSW.The functional outcome was measured as a difference between
the admission and discharge Functional Independence Measure (FIM)
scores. Patients were stratified into four functional severity subgroups based
on their admission FIM (<40, 40–60, 61–80, >80).
Result: 727 patients who completed the rehabilitation program during a 9.5
year period between July 1998 and December 2007 were included in the
study; of these 596 (82%) were CI and 131 (18%) ICH. Patient with ICH
had a significantly greater functional impairment on admission compared
with CI (ICH/CI: admission total FIM 74/88, motor FIM 49/60, cognitive
FIM 25/28). Both groups showed improvement of function with rehabilita-
tion and had similar FIM scores at discharge (ICH/CI: discharge total FIM
102/106, motor 73/76, cognitive 29/30). However, the ICH group showed a
significantly larger change in FIM scores during rehabilitation (ICH/CI: ∆
total FIM 28/18 motor 24/16, cognitive 4/2). The same was true for each of
the four FIM subgroups.
Conclusion: Patients with ICH had greater functional impairment than CI
at admission but showed a better improvement in function with rehabilita-
tion.This was true even when the severity of functional impairment at admis-
sion was taken into consideration. Among stroke patients selected for
rehabilitation, ICH patients have a more favourable outcome for functional
recovery than patients with infarction.
References
1. Jorgensen HS et al. Intracerebral haemorrhage versus infarction: stroke
severity, risk factors and prognosis. Ann Neurol 1995; 38: 45–50.
2. Kelly PJ et al. Functional recovery following rehabilitation after haemor-
rhagic and ischemic stroke. Arch Phys Med Rehabil 2003; 84: 968–72.
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MEASURING PHYSICAL ACTIVITY IN ACUTE STROKE PATIENTS:
OBSERVATION VS DEVICE?
Sharon Kramer1,2, Julie Bernhardt2, Cathy Said3, Tara Purvis2
1Utrecht University, Utrecht, The Netherlands, 2National Stroke
Research Institute, Melbourne, VIC; and 3Austin Health, Melbourne VIC
Background: Higher intensities of physical activity can improve outcome
following a stroke. However, measuring physical activity over the course of a
patients’ day, while desirable, is difficult.
Aims: This study aimed to evaluate: 1) the feasibility of using a device to
measure physical activity in acute stroke patients and 2) agreement between
data derived from a device and systematic observation (behavioural mapping
(BM)).
Method: The physical activity of patients within 14 days of admission to an
acute stroke unit was quantified using a small accelerometer (PAL2, sample
rate 10 Hz) worn over the knee from 0800–1700 hours on a single day. BM
was simultaneously undertaken by a single observer. Activities of interest
were lying, sitting, standing and walking.
Results: 22 patients have been recruited, with 10 completed testing. These
10 patients (50% male) had a mean age of 77 years (range 60–89), an
NIHSS-score ranging from 3–22 and were 3–14 (median 6) days post stroke.
The mean proportion of the day spent in each activity was:
The mean proportion of the day spent in each activity was: Lying BM 56%
(range 24–100%); PAL2 53% (range 16–96%), Sitting BM 36% (range
0–71%); PAL2 44% (range 2–69%), Standing BM 5% (range 0–18%); PAL2
2% (range 0–7%), and Walking BM 3% (range 0–13%); PAL2 1% (range
0–8%). The device was acceptable to patients and malfunction and patient
tampering were rare.
Conclusion: Activity levels in this acute stroke population were low. Data
from the device were similar to that derived from observation (a highly labour
intensive method).The PAL2 is a feasible method to measure activity in acute
stroke.
Concurrent 11 – Themed Presentations
Thursday, 14 August 2008: 1130–1145 h
ACHIEVEMENT OF MOBILITY MILESTONES IN INDIVIDUALS WITH
TOTAL ANTERIOR CIRCULATION SYNDROME STROKES
K Smith1, K Grove1, GT Allison1,2
1Royal Perth Hospital Neurological Rehabilitation Physiotherapy Dept.;
and 2Curtin University School of Physiotherapy
Background: Severe complex stroke provides a unique challenge for neu-
rological rehabilitation and analysis of outcomes is often compromised by
limited length of stay (LOS). Extending LOS with intensive rehabilitation
may have long-term benefits in higher levels of independent function1.
Aims: To quantify achievement of functional milestones in a cohort where
LOS is not used to censor data collection.
Methods: A retrospective analysis of achievement of functional milestones
and LOS of 46 consecutive patients with total anterior circulation strokes
(TACS) was examined at a specialised stroke rehabilitation unit. Cumulative
frequencies were used to determine the % of participants achieving the task
within 1 year and the week in which the task was achieved (median, inter-
quartile ranges) of functional milestones were determined.
Results: Mean (SD) LOS was 119 (73) days in rehabilitation. Cumulative
frequency assessments show continued achievement of functional milestones
during rehabilitation with [% of participants, Median weeks (IQR)] inde-
pendent sit to stand (89%, 9, 4–20), independent transfers (82.6%, 17,
5–32.5) and ambulation (76.1%, 24, 6.5–46).The time when milestones were
achieved show high concordance between specific tasks.
Conclusion: Individuals with TACS and severe functional limitations when
given intensive long-term rehabilitation achieve functional mobility mile-
stones. This may translate to higher levels of independent living and less
ongoing care costs. The concordance of specific functional milestones sug-
gests that there are common capacities that are important elements in each
of these tasks. These findings have important implications in rehabilitation
strategies.
Reference
1. Turner-Stokes L et al. (2006) J Neurol Neurosurg Psychiatry 77: 634–9.
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PREDICTING WHEN INDIVIDUALS WITH TOTAL ANTERIOR CIRCULA-
TION STROKE ARE LIKELY TO ACHIEVE INDEPENDENT STAND STEP
TRANSFERS
K Smith1, K Grove1, GT Allison1,2
1Royal Perth Hospital Neurological Rehabilitation Physiotherapy Dept.;
and 2Curtin University School of Physiotherapy
Background: Total anterior circulation stroke (TACS) results in severe
impairments which translate to poor functional mobility outcomes. The
ability to achieve an independent stand/step transfer (SST) results in an
improved potential for independent living. It has been argued that extended
neurological rehabilitation may be cost effective if fewer individuals are dis-
charged to high dependency care units.1
Aims: To identify if early mobility milestones predict when independent SST
transfers are achieved.
Methods: A retrospective analysis of achievement of functional milestones
of 46 individuals with total anterior circulation strokes (TACS) was exam-
ined at a specialised stroke rehabilitation unit. A stepwise regression was used
on initial functional milestones and stroke assessment score to predict time
in rehabilitation to achieve SST transfers.
Results: 90% achieved independent STS (Median 9wks IQR 4–20) and
85% SST transfers (17, 5–32.5). Chedoke-McMaster Lower Limb score in
week 1 and the week in which independent sitting was achieved were signif-
icant predictors of the time taken to achieve independent stand/step trans-
fers (R2 = 63%, p < 0.001).
Conclusion: Most individuals with TACS achieve independent SST trans-
fers when given sufficient LOS and rehabilitation inputs. A proportion of
these achieved this milestone at times when they would have been discharged
if in other institutions. Our predictive model suggests that early milestone
assessments have some prognostic value.These findings have implications for
rehabilitation planning and the cost utility of extended LOS in neurological
rehabilitation with a focus on optimal milestones achievements and level of
independence.
1. Turner-Stokes L et al. (2006) J Neurol Neurosurg Psychiatry 77: 634–9.
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ASSESSMENT OF THE UPPER LIMB IN ACUTE STROKE: THE VALID-
ITY OF THE HIERARCHAL SCORING METHOD FOR THE MOTOR
ASSESSMENT SCALE
Rebekah Hubbard, Kate Day, Kerry Baker, Mark Parsons
Neurology, Acute Stroke, Allied Health, John Hunter Hospital, NSW
Background: The Motor Assessment Scale (MAS) was developed by Carr
and Shepherd to assess motor function following stroke and is commonly
used in Australia and internationally. Previous studies have examined its reli-
ability and validity, and found it to be within acceptable ranges; however the
validity of the hierarchal scoring remains under scrutiny.
Aim: To determine the validity of the hierarchical scoring system for the
upper limb subscale of the Motor Assessment Scale (UL-MAS) in acute
stroke using Rasch analysis.
Methods: This study applied Rasch analysis to 40 UL-MAS assessment
results to determine the validity of the hierarchy of the three upper limb
subsets: upper arm function, hand movements and advanced hand activities.
Rasch analysis examines the inter-item relationship between ‘item difficulty’
and ‘person ability’. This study recruited inpatients from acute/subacute
stroke units in three Australian metropolitan hospitals and totalled 25 sub-
jects in the acute stage of stroke recovery (14 male, 11 female; average age:
70 years; average time since stroke onset: 4.6 days; 16 left-side affected, 9
right-side affected).
Results: The hierarchy was upheld within subset 6. In subset 7, the hierar-
chy was not upheld. Results indicated that item 3 was the least difficult, fol-
lowed by item 1, 4, 2, 5 and 6 in order of increasing difficulty. In subset 8
the hierarchy was not upheld. Results indicated that item 1 was the least 
difficult, followed by item 6, 2, 5, 3, and 4 in order of increasing difficulty.
Therefore, the hierarchical scoring system is not valid for the UL-MAS.
Concurrent 11 – Themed Presentations
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CLINICAL STREAMLINING OF STROKE PATIENTS ON A GENERAL
INPATIENT REHABILITATION UNIT: ALIGNING PRACTICE TO EVI-
DENCE-BASED GUIDELINES
Robyn Walker, David Kellett, Sarah Moody
Rankin Park Centre, Newcastle, NSW
Background: Rankin Park Centre, Newcastle, NSW is a 40 bed inpatient
general Rehabilitation Unit divided into two 20 bed wards. In March 2007
the decision was made to co-locate patients in specific impairment groups,
rather than individually throughout the unit.This is based on National Stroke
Guidelines suggesting best practice evidence that co-location of stroke
patients’ is shown to improve outcomes.
Aim: The uptake and implementation of clinical guidelines has been iden-
tified as a major challenge. Our aim was to implement change at an organi-
sational level in accordance with current evidence. This formed part of a
broader change of management of patients on our unit.
Methods: The anticipated number of stroke beds was calculated using his-
torical AROC data. Case conference schedule was redesigned. Patient flow
from acute care to the unit was revised. Designated staff attended profes-
sional development to enhance their skills. Stroke patient education was
revised.Working parties formed in post acute stroke nursing and continence
management. Qualitative and quantitative methods of evaluation were
employed.
Results: Providing a co-ordinated approach to the care of stroke patients’ is
providing promising results. Based on AROC data, quantitative pilot results
over the 3 years from 2005 to 2007 indicate a decreased length of stay and
an increase in FIM gain. A decreased waiting time for stroke patients’ to
access inpatient rehabilitation services is also evident. Staff have increased
their knowledge base and are engaging with post acute stroke care.
Conclusion: Geographical co-location of stroke patients’ is a primary
element acting as a change catalyst for the multidisciplinary team to improve
patient outcomes.
Concurrent 12
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WHICH MUSCLES HAVE THE GREATEST IMPACT ON WALKING
SPEED?
Simone Dorsch, Louise Ada, Colleen Canning, Catherine Dean, Matar
Alzahrani
Discipline of Physiotherapy, Faculty of Health Sciences. University of
Sydney, NSW
Background: It is now accepted that following a stroke one of the major
impairments affecting function is loss of strength. However, little is known
about the relative contribution of this impairment to walking.
Aim: The aim of this study is to determine the relative contribution of
muscles of the lower limb to walking speed in people who can walk inde-
pendently following a stroke.
Methods: A prospective descriptive study was carried out on people over 50
years of age, more than 1 year post stroke and able to walk independently.
Strength in the muscles of the lower limb and comfortable walking speed was
measured. Linear regression between the strength of each muscle group and
walking speed was calculated and muscle groups with significant correlations
were put into a multiple regression model to analyse their relative contribu-
tion to walking speed.
Results: The results from 40 participants show significant correlation
between walking speed and muscle strength for hip extensors, hip flexors,
hip internal rotators, knee flexors, ankle dorsiflexors and ankle evertors. Mul-
tiple regression shows that the ankle dorsiflexors make an independent con-
tribution to walking speed.
Discussion: After a stroke, for people to achieve independent walking they
require sufficient strength in the extensor muscles of the leg. However, once
walking has been achieved, it appears to be the muscles that flex the leg to
achieve swing phase of walking that impact on walking speed. These results
suggest that in rehabilitation after stroke, the flexor muscles of the leg should
be strengthened.
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IMPROVING UPPER LIMB FUNCTION AFTER STROKE: A HOME-
BASED AND SELF-DIRECTED TRIAL OF CONSTRAINT INDUCED
MOVEMENT THERAPY
Stephen Isbel1, Chris Chapparo, David McConnell, Judy Ranka
1ACT Health
Background: Cerebrovascular Accident, or stroke ranks as one of the
leading causes of disablement in Australia.1 Motor impairment of the upper
limbs is one of the most common and disabling consequences of stroke. Con-
ventional methods for improving function in the upper limbs following stroke
have had limited success. Constraint Induced Therapy (CI Therapy) is one
method that has shown promising results. Research to date has focused on
the use of this method in institutional based clinical trials.2 The purpose of
this research was to determine the effectiveness of CI Therapy in a home
setting.
Methods: In Phase One of this study a new home-based CI Therapy proto-
col was developed with the involvement of expert and consumer panels.
Phase Two of the study used a non-concurrent, A1/A2 single subject research
design to test the effectiveness of the protocol developed in Phase One on
eight post stroke participants. The treatment consisted of restraining the
intact upper limb in a mitt for 21 days combined with a home-based and
self-directed daily activity regime. All participants were tested pre and post-
treatment using the Wolf Motor Function Test (WMFT) and the Motor
Activity Log (MAL).
Results: Five out of eight participants showed significant improvement on
the WMFT and the MAL.
Conclusion: A home-based and self-directed CI Therapy protocol may
improve upper limb function following stroke.This requires further between
group analysis and if this proves to be effective it may have implications for
community-based post stroke rehabilitation.
References
1. Australian Institute of Health and Welfare. Australia’s Health. Canberra:
Australian Government Printing; 2006.
2. Wolf SL,Winstein CJ, Miller JP,Taub E, Uswatte G, Morris D et al. Effect
of constraint induced movement therapy on upper extremity function 3–9
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WHAT PEOPLE SAY ABOUT TRAVELLING OUTDOORS AFTER THEIR
STROKE: A QUALITATIVE STUDY
Lara Barnsley1, Annie McCluskey2, Sandy Middleton3
1The University of Sydney, NSW; 2The University of Sydney, NSW; and
3National Center for Clinical Outcomes Research (NaCCOR), Nursing
and Midwifery, Australia & Australian Catholic University
Background: Reduced walking ability and loss of confidence are common
after stroke. Many people cannot drive or use public transport, which further
restricts participation.
Aim: This qualitative study explored peoples’ experience of getting out and
about after a stroke, including barriers and enablers.
Methods: Two semi-structured interviews were conducted with 15 people
post-stroke (30 interviews). All participants were receiving therapy sessions
post-stroke to increase outdoor journeys. The first interview was conducted
21 days post discharge (median time) and 55 days post-stroke (median time).
Mean age was 64.5 (SD 8.7 years).The second interview occurred 3 months
later. Interviews were conducted at home. Questions enquired about desti-
nations, driving status, modes of travel, goals and barriers. Qualitative data
were analysed using constant comparison (grounded theory) methods, result-
ing in themes and categories.
Results: Participants were categorised as either a hesitant or a confident
explorer. The hesitant explorers were concerned about their abilities, about
safety and negative consequences.They cautiously explored their community,
initially with an escort then alone.They set modest goals.The confident explor-
ers were constrained by therapist and family rules about independent journeys,
but set more ambitious goals. Barriers to getting out in both groups included
implicit rules set by others, distance to bus stops and driver car dependence.
One-to-one escorted journeys with therapists increased confidence and skills
(walking distances, crossing roads, negotiating shopping malls).
Conclusion: This study provides in-depth information about people’s expe-
riences of resuming community outings, including goals, barriers and
enablers to participation. Therapists were an enabler.
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EVIDENCE FOR SENSORY RETRAINING POST STROKE
SM Schabrun1, S Hillier2
1Research Centre for Human Movement Control, School of Molecular
and Biomedical Science, The University of Adelaide, SA; and 2Centre
for Allied Health Evidence, School of Health Sciences, The University
of South Australia, Adelaide, SA
Background: Deficits in sensation are a common and well documented
problem post stroke with more than 60% of patients presenting with some
form of sensory loss. Despite these high figures, uncertainty remains regard-
ing the most effective treatment strategy.
Aims: Here we examined the volume and quality of the evidence available
for both passive and active sensory training post stroke. In addition, we sought
to quantify the effect of passive and active sensory training on impairment
and function post stroke.
Methods: A systematic search of the literature was used to identify studies
utilising passive or active sensory training paradigms in stroke patients.
Methodological quality was examined using the National Health and Medical
Research Council hierarchy of evidence and the McMaster University criti-
cal appraisal tool. Where possible, data were pooled for meta-analysis (rela-
tive risk, 95% CI, random effects).
Results: 14 studies were retained for inclusion in this review; 8 examined
passive, and 6 active, sensory retraining protocols. Methodological quality
scores ranged from 11 to 18.5 (maximum 20). Overall effects were positive
for passive sensory stimulation using a measure of hand function (3 studies,
p = 0.006). Single studies offered positive effects using Brunnstrom stages (p
= 0.002) for passive, and sensory detection tests (p = 0.06) for active sensory
retraining.
Conclusions: There is growing evidence for the inclusion of passive, and to
a lesser extent, active sensory retraining paradigms in stroke rehabilitation.
However, there is a need for further research utilising strong methodological
designs to further elucidate the benefit of sensory retraining post stroke.
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EVALUATION OF A STROKE SURVIVOR AND CARER INPATIENT
SUPPORT PROGRAMME
Jenny Burrows
Gosford Hospital. Northern Sydney Central Coast Area Health Service,
NSW
Abstract not to be published.
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APHASIA THERAPY IN THE ACUTE HOSPITAL SETTING: IS IT 
JUSTIFIED?
Erin Godecke1, Kathryn Hird2, Erin Lalor3
1Stroke Unit and Neurology, Royal Perth Hospital, WA; 2Notre Dame
University, Fremantle, WA; and 3National Stroke Foundation, Mel-
bourne, VIC
Introduction: Robey (1998) reported that people who receive intense
aphasia therapy in the acute phase have more than twofold the improvement
of those treated in the chronic phase. Despite such evidence, conjecture
regarding the optimum timing, intensity and duration of rehabilitation per-
sists (Kwakkel et al., 2004).
Method: A prospective randomised, open labelled, single blinded study was
conducted to determine the impact of daily aphasia therapy in the acute
setting on communication outcomes at discharge and at 6 months post
stroke. Participants (N = 59) were randomised to either daily or weekly
therapy while in hospital (χ = 22 days).
Results: A principal component analysis identified three clusters of outcome
measures that displayed a significant between group difference at acute dis-
charge and at 6 months. When stroke severity, initial aphasia severity and
gender were controlled, patients who received daily therapy, showed signifi-
cantly better outcomes than those who received weekly therapy. Results of a
longitudinal random-effects regression analysis to determine prognostic
factors influencing communication status at 6 months post stroke will be 
discussed.
Conclusions: This study showed that despite large inter-subject variability,
people with moderate-severe aphasia who received daily therapy in the acute
hospital setting made significantly positive gains in effective communication
skills at hospital discharge and that these gains were maintained at 6 months.
This study showed that aphasia therapy in the acute hospital setting is ben-
eficial and appropriate for people with moderate-severe aphasia. Discussion
will focus on addressing who benefits from therapy and how much therapy
is appropriate in the very early recovery phase.
Concurrent 13
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WHAT ARE THE MOST APPROPRIATE STROKE OUTCOME 
MEASURES?
Jeffrey Saver
Geffen School of Medicine at UCLA, USA
Like all diseases, stroke affects persons in their biologic, functional, social,
and experiential dimensions, necessitating measures of deficit, disability,
handicap, and quality of life. As a neurologic disease, stroke alters the cardi-
nal domains of human behavior, including language, spatial, executive, affec-
tive, motor, and visual function. Stroke cripples as well as kills, resulting in
outcomes spread over the entire range from normal to disabled to dead.
Hence the challenge to those who seek to assess the benefits and risks of
treatments for stroke.
Amidst this complexity, the most appropriate outcome measures and sta-
tistical analytic techniques for assessing stroke interventions are those that
measure all outcomes that the treatment being tested might alter, in pro-
portion to the degree they are valued by the patient.
This principle has driven four recent advances in stroke trial endpoint
design:
1) DALYs: For vascular disease prevention trials, the WHO’s disability-
adjusted life years (DALY) measure provides a uniform metric for all
disease states. For the typical stroke patient, immediate vascular death
deprives the individual of xx disability-adjusted life years, nonfatal stroke
yy DALYs,and nonfatal MI aa DALYs.
2) Distribution of Treatment Effects: Ranked vs dichotomized endpoint
selection for stroke trials should be guided by recent findings that: 1)
recanalization treatments applied in the first 3 hours tend to produce ben-
efits clustered at extreme good outcome, 2) recanalization therapies deliv-
ered in the 3–8 hour window benefits clustered at moderate good
outcomes, and 3) neuroprotective therapies widely distributed benefits.
3) Numeric Decision Aids: For bedside decision-making, number needed to
treat and number needed to harm indices that incorporate effects across
all health state transitions will be of the greatest value to patients, family
members, and physicians. These can now be derived from ordinal dis-
ability scales using joint outcome table specification techniques.
4) Visual Decision Aids: Visual aids to communicate potential benefit and
risk of stroke treatments should disambiguate short term outcomes (e.g.
early dramatic recovery, SICH) from final outcomes (e.g. final global
functional state) and visually privilege the final outcome that is of great-
est relevance to patient and family decision-makers. New visual displays
to convey the benefits and risks of intravenous and of intra-arterial throm-
bolytic therapy for stroke will be presented.
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THE INTERACT TRIALS
Craig Anderson
On behalf of the INTERACT Investigators
Background: There is much uncertainty about the effects of early lowering
of elevated blood pressure (BP) in acute intracerebral haemorrhage (ICH).
Methods: The first Intensive Blood Pressure Lowering in Acute Cerebral
Haemorrhage Trial (INTERACT) was a multi-centre, open, blinded
outcome, randomised controlled trial, which compared the effects of a man-
agement strategy of early intensive BP lowering (target systolic BP of 140
mmHg) to one based on a standard clinical guideline (target systolic BP of
180 mmHg) in 404 patients with acute spontaneous ICH diagnosed by com-
puterized tomography (CT) within 6 h of onset associated with elevated 
systolic BP (≥150 and ≤220 mmHg) and no definite indication or con-
traindication to treatment. The primary efficacy endpoint was proportional
change (‘growth’) in haematoma volume at 24 h. Secondary efficacy out-
comes included other haematoma volumetric parameters. Safety and clinical
outcomes were assessed up to 90 days.
Findings: At baseline, the characteristics of patients were similar between
groups, but mean haematoma volumes were slightly smaller in the control
group (12.7, SD 11.6) compared with the intensive group (14.2, SD 14.5).
From randomization to 1 h, mean systolic BP was 153 mmHg and 167
mmHg in the intensive and guideline groups, respectively (difference 13.3
mmHg, p < 0.0001), and from 1 to 24 h, levels were 146 and 157 mmHg,
respectively (difference 10.8 mmHg, p < 0.0001). Mean proportional
haematoma growth was 36.3% in the guideline group and 13.7% in the
intensive group, a significant difference of 22.6% (95% confidence interval
[CI] 0.6–44.5%; p = 0.04) at 24 h. After adjustment for initial haematoma
volume and time from onset to CT, the difference was borderline significant
(adjusted p = 0.06). Likewise, ‘substantial’ haematoma growth (i.e. >33% or
>12.5 mL) was 36% (95% CI 0–59%, p = 0.05) lower in the intensive group.
Intensive BP lowering treatment did not alter the risks of adverse events nor
clinical outcomes at 90 days.
Conclusions: Early intensive BP lowering is clinically feasible, well toler-
ated, and appears to produce modest attenuation of haematoma growth in
ICH. The main phase, INTERACT2, aims to determine the effects of the
treatment on death and dependency in 2,800 patients (half treated within 4
h of onset). This presentation will overview the primary results, present data
on secondary analyses, and outline plans for INTERACT2.
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THE AUSTRALIAN NATIONAL CLINICAL AUDIT OF ACUTE HOSPITAL
STROKE SERVICES
Dominique A Cadilhac1, Graeme Hankey2, Dawn Harris3, Susan Hillier4,
Monique Kilkenny1, Erin Lalor3; On behalf of the National Stroke Foun-
dation Advisory Committee: National Stroke Audit Acute Services and
the National Stroke Audit Collaborative
1National Stroke Research Institute, Heidelberg Heights, VIC; 2Royal
Perth Hospital, Perth, WA; 3National Stroke Foundation, Melbourne,
VIC; and 4School of Health Sciences, University of SA, Adelaide, SA
Background: Australian clinical guidelines for acute stroke were produced
in 2003. The extent of implementation of these guidelines has never been
quantified. The aim of the 2007 Clinical Audit was to assess adherence to
evidence-based care and to describe the variations in stroke services across
Australia. The Clinical Audit examined those processes of care derived from
the Clinical Guidelines as evidence-based best practices.
Methods: Clinicians at participating sites conducted a retrospective audit for
40 patient case notes admitted between 1 October 2006 and 31 March 2007.
Results: 89 hospitals (estimated as providing 68% of inpatient stroke care,
National Stroke Audit Organisational Report Acute Services 2007) partici-
pated in the Clinical Audit. In total, 2,724 case notes were audited. In those
with ischemic stroke, 3% of eligible patients received IV thrombolysis and
92% received aspirin within 48 h. 50% audited patients were managed on a
stroke unit. Half the patients audited received a swallowing screen. Of the
audited patients, there was no care plan provided for 54%, 47% did not
receive education, and 17% of patients did not have a discharge summary
sent to their GP. Stroke Units hospitals consistently demonstrated greater
adherence to the guidelines.
Conclusions: Analysis of the audit data has provided insights into uptake of
the clinical guidelines. The data represented care across all phases of acute
care including early interventions, timely assessment by allied health and dis-
charge planning processes. The audit provides a focus for developing action
plans to improve clinical practice and patient outcomes over time.
Concurrent 15 – Platform Session
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EFFECTIVENESS OF POST STROKE FOLLOW-UP IN PATIENTS WITH
STROKE LIVING IN THE COMMUNITY
A Skrypnyk, N DeVries, Markus R
Acute Stroke Unit, St Vincent’s Hospital, Sydney, NSW
Background: Stroke survivors in the community report being dissatisfied
with support and information provided post discharge home. A prior study
demonstrated that less than half of patients perceived having specialist stroke
care and education post discharge, and a smaller proportion reported seeing
a neurologist or discussing stroke prevention with their general practitioner
(GP).
Aims: (i) To assess the effectiveness of a Stroke Liaison Nurse (SLN) in
improving patient knowledge and participation in secondary prevention mea-
sures. (ii) To determine if SLN follow-up improves access to specialised
stroke care.
Methods: Consecutive patients discharged home and their GPs were fol-
lowed-up by a SLN over a 5-month period. This group was contacted at 
3 months post-discharge and patient perception of adequacy of follow-up
and participation in secondary prevention was ascertained by structured
questionnaire.
Results: 103 patients were screened, of which 50 were discharged directly
home. 41 patients were contactable for follow-up and 38 completed the ques-
tionnaire. 31 (82%) of respondents felt that they had received adequate infor-
mation on stroke and secondary prevention. 32 (84%) were confident and
knowledgeable with their current medications. 24 (63%) stated that they dis-
cussed stroke risk reduction with their GP. 28 reported seeing a neurologist
post discharge, 5 patients did not require neurology follow-up within the 3
months post discharge.
Discussion: Effective secondary stroke prevention requires adequate follow-
up of stroke survivors. Post discharge coordination increases the patients’
knowledge of stroke and secondary prevention, improves risk reduction par-
ticipation with GP’s, and improves access to specialised stroke care. These
results support making Stroke Liaison Nurse standard practice in stroke care.
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DOES STROKE UNIT DISCHARGE PLANNING MEET THE POST-
DISCHARGE NEEDS OF STROKE SURVIVORS AND THEIR CARERS?
Julie Luker1, Karen Grimmer-Somers2
1Flinders Medical Centre, SA; and 2Centre for Allied Health Evidence,
University of SA
Background: Better discharge planning practices are advocated to improve
stroke patients’ transition from acute care to the community.1 However, there
has been little investigation of discharge plans in terms of how well they meet
stroke survivors’ short and long term needs.
Aim: To establish whether discharge planning for stroke patients admitted
to an acute stroke unit, met their needs post-discharge.
Study Setting & Design: This was a two part study of 50 stroke survivors.
(i) Semi-structured patient interviews 6 weeks and 6 months after discharge,
to establish patient perspectives. (ii) Retrospective patient record audit of 
discharge planning activity against three relevant stroke guideline 
recommendations.1
Results: During the 6 months post-discharge, 36% of stroke survivors expe-
rienced unexpected hospital readmissions and 24% moved to more sup-
portive long-term accommodation than was anticipated at initial discharge.
For the 29 survivors living at home at 6 weeks, patterns of community
support usage differed from the audited discharge plans, with 38% having
arranged additional support for themselves by that time. At 6-month follow-
up 32% had arranged more community support than was needed at 6 weeks.
Discharge planning practices in the stroke unit were not significantly associ-
ated with patients’ community support experiences post-discharge.
Conclusions: In the 6 months after hospital discharge, stoke patients expe-
rienced numerous changes in community support and accommodation needs
which were not anticipated in discharge planning.This indicates that current
discharge planning practices are ineffective for many stroke survivors. Dif-
ferent support models are required in the acute and subacute phases of stroke
recovery.
Reference
1. National Stroke Foundation 2007. Clinical Guidelines for Acute Stroke
Management
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ESTABLISHING A ‘NURSE RUN’ POST ACUTE STROKE CLINIC
Cathie Crowe, Agnieska Jakielska, Deborah Arguedas, Jeanette
Stewart
Liverpool Hospital, Sydney, NSW
Background: It has been identified that management of post-stroke patients
discharged from the acute stroke unit needed to be more effective to facili-
tate recovery and secondary prevention. To address this issue, a ‘nurse run’
Post Acute Stroke Clinic (PASC) was established at Liverpool Hospital in
May 2006.
Aims: To provide acute stroke unit patients with consistent post-stroke care
4–6 weeks following discharge. Focus of the PASC is to monitor patient
progress, identify modifiable risks (eg. blood pressure, smoking, exercise &
diet), educate patients and provide early detection and intervention of cog-
nitive deficits and psychological difficulties (e.g. depression).
Methods: Between April 2007 and March 2008, 95 patients were identified
in a weekly multidisciplinary stroke case conference and referred to the
PASC.These patients underwent blood pressure monitoring, review of med-
ications and risk factors, target setting and screening for depression. Urgent
medical and psychological findings were addressed and followed-up by a
Neurologist and Clinical Neuropsychologist. A 3-month follow-up ques-
tionnaire was conducted by a nurse via phone, and patient satisfaction
surveys were distributed.
Results: Potential complications were identified in 72% patients. 30% were
identified as experiencing mild to severe symptoms of depression. 60% were
referred to a Clinical Psychologist. 39% underwent neuropsychological
screening to identify cognitive deficits likely to impact on daily functioning
and psychological status was monitored over time.
Conclusion: The PASC appears to provide effective secondary prevention
to patients post-stroke and early intervention of cognitive and psychological
difficulties appears to facilitate recovery. This suggests that the PASC pro-
vides a valuable service.
Concurrent 15 – Platform Session
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MULTIDISCIPLINARY TEAM INTERACTIONS IN STROKE UNITS:
COULD DIFFERENCES IN THE ENGAGEMENT OF NURSES HELP
EXPLAIN VARIATIONS IN PUBLISHED PATIENT OUTCOMES BETWEEN
STROKE UNITS?
Tara Purvis1,3, Dominique Cadilhac1,2,4, Julie Bernhardt2
1Department of Medicine, University of Melbourne, VIC; 2National
Stroke Research Institute, Heidelberg, VIC; 3Department of Physiother-
apy, Austin Health, Heidelberg, VIC; and 4Department of Public Health,
University of Melbourne, VIC
Background: Multidisciplinary care is a fundamental component of effec-
tive stroke unit (SU) management. Quantitative audits provide limited
insights into the dynamics and features of multidisciplinary stroke teams.
Given that, evidence from randomised controlled trials suggests that not all
SUs perform equally well, qualitative analysis is a valuable means to explore
differences in care.
Aims: To explore staff perceptions regarding the functioning of multidisci-
plinary teams (including staff training and team work) within two established
SUs in Melbourne, Australia and Trondheim, Norway, and to identify areas
for practice improvement within Australian SUs when compared with the
internationally recognised ‘gold standard’ Trondheim unit.
Methods: In-depth, semi-structured interviews (n = 7) were conducted with
key multidisciplinary staff from each site. All interviews were recorded on
audio tapes, then transcribed and confirmed by interviewees.Thematic analy-
sis was used whereby a coding tree was formulated to identify major themes
and subthemes. Coded interview data were then summarsied. Another
researcher verified the coding and summary.
Results: Fundamental differences in the functioning of multidisciplinary
teams at the two SUs were noted. In particular, weekend care practices, staff
training opportunities and team work varied markedly. These differences
centred primarily on nursing involvement. Nurses appeared more integral to
the multidisciplinary team in Trondheim, were strongly involved in decision
making, and assisted in providing comprehensive 24-h patient care.
Conclusion: The results of this study offer insights into stroke unit multi-
disciplinary teams that could help improve care in Australian SUs and facil-
itate better patient outcomes.
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EFFECTIVENESS OF THE CHIN TUCK STRATEGY IN REDUCING
LARYNGEAL ASPIRATION IN POST STROKE DYSPHAGIA; A PILOT
STUDY OF PATIENTS PRESENTING WITH RIGHT HEMISPHERE COR-
TICAL STROKE
Abstract withdrawn
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FEAR OF FALLING AND FALLS AFTER STROKE: THE CHICKEN OR THE
EGG?
Frances Batchelor, Keith Hill, Shylie Mackintosh, Catherine Said, 
Craig Whitehead, Caroline Fryer, Bronwyn Keller, Sue Hunt, 
Karen Borschmann, Freda Vrantsidis
National Ageing Research Institute, University of Melbourne, 
Melbourne, VIC
Background: Falls are common in community-dwelling stroke survivors.
Fear of falling (FOF) is also common and may have a negative impact on
function and quality of life. It is currently unclear how FOF changes over
time and what causal relationship exists between function and falls.
Aims: To examine change in FOF over time and the effects of falls and a
falls prevention program on balance self-efficacy in stroke survivors dis-
charged home after rehabilitation.
Methods: Participants involved in a randomised controlled trial were
recruited from six sites in Melbourne and Adelaide. As part of this trial, mea-
sures of fear of falling (Falls Efficacy Scale Swedish Modification – FES-S),
balance, gait and activity were collected at baseline and after 12 months, and
at approximately 4-monthly intervals (Melbourne only).
Results: 101 participants (mean age 72 years, 67% male) were recruited
with 20 to date completing 12-month follow-up. Considering the overall
sample, there were no significant differences between FES-S at baseline and
any time-point.When comparing control and intervention groups, there was
no significant difference in FES-S at baseline, however, there was a signifi-
cant difference in FES-S between baseline and 12 month follow-up for inter-
vention participants only, with intervention participants improving and
control participants showing a non-significant trend towards decreased
balance confidence. There was no significant difference in FES-S change
from baseline to final follow-up for fallers compared with non-fallers.
Discussion: These preliminary results indicate that a falls prevention pro-
gramme (exercise, risk factor modification and education) may help to
improve balance confidence for stroke survivors; however, a larger sample is
required.
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MANAGEMENT STRATEGIES FOR DEPRESSION AFTER STROKE: IS
THERE NEW EVIDENCE SINCE 2004?
ML Hackett, AO House, CS Anderson
The George Institute For International Health, NSW
Background: Our Cochrane reviews from 2004 demonstrated the lack of
evidence for the management of depression after stroke.
Methods: We updated our reviews of randomised controlled trials compar-
ing pharmaceutical agents (with placebo), or psychotherapy (with standard
care or attention control) to treat or prevent depression in patients with
stroke. The primary endpoint was the proportion of patients who met the
diagnostic criteria for depression applied in the trials at the end of treatment.
Secondary outcomes included depression or mood scores on standard scales,
disability or physical function, death, recurrent stroke and adverse effects.
Results: 30 trials involving 3129 participants were included. Data were avail-
able for 23 pharmaceutical (25 comparisons) and 7 psychotherapy trials.
There was no clear effect of pharmacological therapy on the prevention of
depression or other endpoints. A significant improvement in mood and the
prevention of depression was evident for psychotherapy (OR 0.64; 95% CI
0.42–0.98). In the treatment trials there was evidence of benefit of pharma-
cotherapy in terms of complete remission of depression (OR 0.47, 95% CI
0.22–0.98) and a reduction (improvement) in scores on depression rating
scales, but there was also evidence of an associated increase in adverse events
(OR 1.71, 95% CI 1.34–2.18). There was no evidence of benefit of psy-
chotherapy in treating depression after stroke.
Conclusions: There is stronger evidence for psychotherapy (but not phar-
macotherapy) for preventing depression after stroke. Pharmacotherapy (but
not psychotherapy) should be used with caution for treating depression after
stroke in light of the increase in adverse events.
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APHASIA-FRIENDLY MATERIALS – ARE WE REALLY PRODUCING
THEM?
Maria Berarducci, Lauren Cooper, Victoria Giles
Sacred Heart Rehabilitation Service, St Vincent’s Hospital, Sydney,
NSW
Background/Aims: As part of our drive to incorporate evidence-based prac-
tice into day-to-day clinical practice a project was undertaken to assess
Printed Education Materials (PEMs) in terms of meeting aphasia-friendly
principles at a Rehabilitation Unit. PEMs are frequently used to facilitate
patient access to important health information. However, patients with
acquired language disorders, such as post stroke aphasia, may have difficulty
accessing these forms of information.
Method: Characteristics of aphasia-friendly materials were identified from
the literature and concatenated into a checklist. Seven brochures were eval-
uated for readability and their adherence to the aphasia-friendly checklist
designed. Readability scores were calculated using the Flesch-Kincaid Grade
Level Score.
Results: The brochures evaluated scored between 57% and 82% on the
checklist for aphasia-friendly materials. One of the seven brochures met our
target criterion of above 80%, with a score of 82% while another narrowly
missed it, with 79%. The brochures scored between 6.4 and 11.3 for their
grade level readability scores. Inter-rater reliability averaged 98%.
Conclusion/Discussion: This approach is a relatively quick and practical
way in which healthcare workers can improve the significant barriers that
people with language difficulty face in terms of communicative access. It is
suggested that all PEMs comply with aphasia-friendly principles such as
those identified and discussed in this presentation. Using aphasia-friendly
principles facilitates access to and retention of information for people with
acquired language disorders (Worrall et al., 2007) and may also assist people
with cognitive disorders, limited literacy skills and those with English as a
second language.
Reference
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evidence-base for accessibility for people with aphasia. Aphasiology 2007;
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BENCHMARKING SPEECH PATHOLOGY REHABILITATION OUTCOMES
FOR STROKE. HOW DO WE COMPARE?
Vanessa Aird1, Kerry Gilsenan2, Rachel Miles3, Sarah Townsend4
1Royal Rehabilitation Centre Sydney, NSW; 2Braeside Hospital, Sydney,
NSW; 3War Memorial Hospital, Sydney, NSW; and 4Balmain Hospital,
Sydney, NSW
Abstract not to be published.
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IS THERE A NEED FOR ENGAGEMENT IN MEANINGFUL ACTIVITY
DURING STROKE REHABILITATION?
Louise Gustafsson, Kryss McKenna
The University of Queensland, Qld
Abstract not to be published.
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THE ROLE OF ARBS IN STROKE PREVENTION
Craig Anderson
Global Co-Chair and Asia-Pacific Regional Leader of the ONTARGET
study; Director of the Neurological and Mental Health Division at The
George Institute for International Health, Royal Prince Alfred Hospital
and the University of Sydney, NSW
Background: Angiotensin converting enzyme (ACE) inhibitors have been
clearly shown to improve health through the prevention of cardiovascular
(CV) death, myocardial infarction, stroke and heart failure in high-risk indi-
viduals (those with coronary artery disease or diabetes and multiple risk
factors) without heart failure. However, ACE inhibitors cause cough in many
people, and much less frequently but potentially more serious, the side effect
of angioneurotic oedema. Thus, angiotensin receptor blockers (ARBs) offer
the potential for being an equally useful therapy but with fewer side effects.
However, there has been uncertainty over the benefits of ARBs when com-
pared with ACE inhibitors, and of any additional benefits of the combina-
tion treatment. The ONTARGET study evaluated (a) whether telmisartan,
an ARB, would be as effective as ramipril, an ACE inhibitor, but with fewer
side effects, and additionally (b) whether the combination of telmisartan plus
ramipril, compared with ramipril alone, was more effective in high risk CV
patients.The primary endpoint was CV death, myocardial infarction, stroke,
or hospitalization for heart failure.
Methods: ONTARGET study was an academic-industry partnership study
which used a run-in phase, parallel group, double-blind, double-dummy ran-
domised design, conducted in 733 centres from 41 countries, thus making it
the largest ever clinical trial in people at high risk of CV disease. The study
enrolled patients with established CV disease as evident by coronary artery
disease, cerebrovascular disease, peripheral vascular disease, or diabetes with
additional risk factors, who were over the age of 55 years, and did not have
any evidence of heart failure. Patients were randomised to receive ramipril
10 mg a day, telmisartan 80 mg a day, or the combination of the two, and
then followed up for an average period of 4.5 years, between 2001 and 2007.
Results: These have been published (NEJM 2008; 358: 1547–59.). In brief,
a total of 25,620 patients (av. age 66 years) were included: 27% women, 38%
with diabetes, 69% had a history of hypertension, 75% had coronary artery
disease, 16% had a history of stroke, and 14% had evidence of peripheral
arterial disease. These patients used many other proven therapies for their
condition. At randomisation, their mean blood pressure was 134/77 mmHg
(systolic/diastolic, sitting). The three randomised groups were well balanced
for baseline factors and the patients showed a high level of adherence to the
treatment and protocol during follow-up. Measures of quality were high in
the study. Telmisartan was shown to be significantly non-inferior and with
slightly better tolerability to ramipril, while combination therapy did not
provide any additional benefit and was associated with problems of tolera-
bility and some excess in hazard. Analysis of the secondary endpoints of
stroke, and its pathological subtypes, and on cognitive function suggests
superiority of telmisartan over rampril.
Conclusions: Telmisartan was equivalent to ramipril in patients with vas-
cular disease or high risk diabetes, while the combination of the two drugs
was associated with more adverse events without an increase in benefit.
The implications of the ONTARGET results for clinical practice will be 
discussed.
Concurrent 18
Concurrent 18 – Workshop
Thursday, 14 August 2008: 1530–1700 h
BOTULINUM TOXIN (BTX) FOR POST STROKE SPASTICITY – PATIENT
SELECTION, PLANNING AND POST PROCEDURAL THERAPY
Steven Faux
A series of four cases on the use of botulinum toxin (BTXA) and functional
electrical stimulation (FES) to improve upper limb function in stroke sur-
vivors during the sub-acute phase. The four cases represent the pilot phase
of a prospective single blinded study.
All four patients were commenced on Botulinum Toxin to hypertonic
muscles (mostly flexor) in the upper limb with a power of 1/5 and which were
recruited in a mass action pattern. The functional Electrical stimulator was
applied to the antagonist muscles (mostly extensors) and used for 3 h per
day for 3 months.
In all patients there was no significant change to NIHSS score, or func-
tional status after 3 months of treatment. There was, however, significant
change in Motor Assessment score indicating some improvement in move-
ment. One patient developed finger movement at 12 months post treatment.
The four cases may suggest that early use of botulinum toxin and FES was
effective in improving movement but not effective at improving upper limb
function in the short term. fMRI correlates may be of interest in the future
and may elucidate whether subtle changes were present.
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Concurrent 19 – Workshop
Thursday, 14 August 2008: 1530–1700 h
IMPROVING OUTCOMES IN IMPAIRMENT-BASED INTERVENTION
FOR SPEECH AND LANGUAGE PRODUCTION
Kirrie Ballard
University if Sydney, NSW
Treatment outcome studies over the past 15 years have identified a set of
principles that optimise long-term maintenance of treated speech/language
skills and generalisation to other skills that are systematically related to
treated skills. These studies have demonstrated improvements in adults with
both sub-acute and chronic impairment. In this workshop, these principles
will be presented, with supporting evidence from studies of motor speech
disorders (e.g. Apraxia of Speech) and nonfluent aphasia. To facilitate trans-
lation of this research into clinical practice, small group activities will involve
discussion of cases and how to develop management plans that implement
these principles.
Concurrent 20
Concurrent 20 – Themed Presentations
Friday, 15 August 2008: 1300–1317 h
THE FREQUENCY OF TIA MIMIC AND STROKE DISCHARGE DIAGNO-
SIS IN PATIENTS ADMITTED TO LIVERPOOL HOSPITAL, SYDNEY,
FROM JANUARY 2003 TO DECEMBER 2007 WITH AN EMERGENCY
DEPARTMENT (ED) DIAGNOSIS OF TIA
Dennis Cordato, Peter Thomas, Darshan Ghia, Roy Beran, 
Cecilia Cappelen-Smith, Neil Griffith, Ibrahim Hanna, Alan McDougall,
John Worthington, Suzanne J Hodgkinson
Department of Neurology, Liverpool Hospital, NSW
Aims: To determine (i) frequency of TIA (transient ischemic attack) mimic
disorders and stroke diagnosis, (ii) differences in vascular risk factor charac-
teristics, for all subjects admitted to Liverpool Hospital from January 2003
to December 2007 with ED (Emergency Department) diagnosis of TIA.
Methods: All patients with ED diagnosis of TIA (ICD-9-CM) from January
2003 to December 2007 were identified. ED records were matched with hos-
pital admission records to determine ICD-10-AM final diagnosis. Additional
diagnosis of hypertension, hyperlipidaemia, diabetes mellitus, atrial fibrilla-
tion and history of smoking were compared for patients with final diagnosis
of TIA, stroke or ‘other’ diagnosis.
Results: 604 patients were admitted with ED diagnosis of TIA. 187 patients
(31%) had final diagnosis of stroke including 7 with intracerebral haemor-
rhage. 109 patients (18%) had ‘other’ diagnoses. Of these, 63 were neuro-
logical, 46 were non-neurological. Patients with TIA or stroke were more
likely to have hypertension compared with patients with ‘other’ diagnoses
(Odds Ratio 1.8, 95% CI 1.15–2.78, p = 0.01 and OR 2.48, 95% CI
1.53–4.02, p = 0.0002, respectively). Stroke patients were more likely to have
hyperlipidaemia and atrial fibrillation compared with patients with ‘other’
diagnoses (OR 1.78, 95% CI 1.05–3.04, p = 0.03, and OR 2.41, 95% CI
1.06–5.47, p = 0.03, respectively).
Conclusions: Patients with ED diagnosis of TIA commonly have final diag-
nosis of stroke or ‘other’ diagnosis. Vascular risk factors such as hyperten-
sion, hyperlipidaemia and AF are less common in patients with ‘other’
diagnoses. Hospital admission of patients with ED TIA diagnosis improves
accuracy of diagnosis and most appropriate long-term treatment strategies.
Concurrent 20 – Themed Presentations
Friday, 15 August 2008: 1317–1334 h
FASTER – FACE, ARM, SPEECH, TIME – EMERGENCY RESPONSE:
EXPERIENCE OF CENTRAL COAST STROKE SERVICES IMPLEMENTA-
TION OF A PRE-HOSPITAL NOTIFICATION SYSTEM FOR EXPEDIENT
MANAGEMENT OF ACUTE STROKE
W O’Brien, J Sturm, W Donaldson, R Risti, T Clarke, S Whyte, 
D Crimmins
Gosford Hospital, Gosford, NSW
Background: Sub-3 h thrombolysis has proven long-term benefit in acute
ischaemic stroke (AIS). 3% of AIS receive lytic therapy in Australia. Delays
in chain of referral from stroke onset to assessment by the Acute Stroke Team
(AST) are manyfold. The FASTER protocol was constructed to reduce pre-
hospital and Emergency Department delays and improve access to acute
stroke therapy.
Aims: To determine if use of the FASTER protocol reduces time to assess-
ment and increases use of tPA.
Methods: A pre-hospital assessment tool (developed in the Hunter region)
was used by Ambulance Services to screen potential candidates. Those ful-
filling criteria were referred to Ambulance Northern Operations Control who
alerted the AST, consisting of the Stroke Fellow and On-call Neurologist. If
accepted, hospital bypass direct to Gosford Hospital was allowed.Triage and
CT were alerted and potential thrombolysis patients were assessed in ED.
Data was collected prospectively during first 6 months of the protocol and
compared with a similar 6 months prior to protocol initiation.
Result: During the first 6 months of protocol introduction, 115 patients were
admitted with confirmed diagnosis of AIS to Gosford Hospital. 19% (n =
22) received open label thrombolysis. A similar period spanning 2006–2007
had 67 admissions with 7% (n = 5) receiving tPA. 42 patients were referred
via the FASTER protocol. 20 patients received lysis therapy. 22 patients were
not treated. 18 fulfilled FASTER criteria but did not meet tPA criteria. 4 did
not fulfil FASTER criteria.
Conclusion: Fast-track referral involving Ambulance Services, Emergency,
Radiology and the Acute Stroke Team is effective in improving patient access
to proven therapy.
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Friday, 15 August 2008: 1334–1351 h
ARE WE THERE YET? BENCHMARKING AN ACUTE STROKE UNIT –
MIDDLEMORE HOSPITAL NEW ZEALAND
P Choi, M McCallin, S Winters, A Kumar, P Owens
Middlemore Hospital, Auckland, New Zealand
Background: Middlemore Hospital participated in the Australasian Stroke
Foundation Audit (May 2007) and subsequently performed an internal audit
to compare performance with the Royal College of Physicians UK Sentinel
Audit of 2006. These audits highlighted poor performance in four Key 
Performance Indicators: aspirin within 24 h swallow assessment, weight and
mood documentation. A stroke checklist was developed and education/
awareness sessions targeting key nursing and medical staff hospital-wide were
implemented.
Aim: To assess if short education sessions to strategic areas in conjunction
with a stroke checklist have improved performance in these four KPIs.
Method: Retrospective audit of all stroke patients admitted to Middlemore
Hospital between 01/09/07 and 14/04/2008 with an ICD Classification of
stroke by ICD-10 code I61, I63, I64 followed by a re- audit 6 months post
education sessions. Audit and education sessions were performed by the
members of the Stroke Multidisciplinary Team.
Inclusion: Intracerebral haemorrhage, cerebral infarction, stroke.
Exclusions: SAH, SDH, bleed into tumour, post traumatic haemorrhage,
Transient Ischaemic Attack.
Results: Aspirin within 24 h increased by 16%, swallowing assessment by
15%, weight by 10% and mood by 21%. Performance in other KPI’s not
covered by teaching sessions also improved.
Conclusion: Targeted education sessions to key staff have been shown to
improve KPI performance when delivered in conjunction with a memory aid
such as a checklist. Further teaching sessions aimed at other KPI’s may
further improve stroke care at Middlemore Hospital.
Concurrent 20 – Themed Presentations
Friday, 15 August 2008: 1351–1408 h
MANAGING TIA IN NEW SOUTH WALES: A BASELINE STUDY TO
DETERMINE CURRENT PRACTICE AND AS A GUIDE TO FUTURE
DIRECTION
Susan Day, Catherine Storey
Department of Neurology, Royal North Shore Hospital, St Leonards,
NSW
Background: TIA can precede a stroke in a significant number of patients.
Recent research demonstrates that the risk may be early and that a high-risk
cohort can be identified and this has led to a more aggressive approach in
many stroke centres.
Aim: To identify the current models of care for TIA presenting to NSW hos-
pitals to form the basis for a more aggressive plan for future services.
Methods: A survey was sent to all NSW hospitals (30) providing acute stroke
services (both rural and metropolitan). Each director was asked to identify
their current model of care for TIA patients, the policy that directed initial
management, in addition to identifying the preferred model and future direc-
tion of their unit.
Results: A 100% response rate was achieved. Hospitals were classified in
two groups according to the complexity of the service. In the high-level ser-
vices (21/30), 7 units admitted all TIA patients, while 14 identified high risk
for admission according to various criteria. Low risk patients were referred
to neurovascular clinics in 5 units. In the lower level services (9/30), 4 admit-
ted all patients, often to a medical unit, while the remainder identified those
at high risk again.There was no consistent plan for future direction, although
both groups identified that a rapid access clinic either out-patient or in-
patient was their preferred model.
Conclusion: This preliminary survey has identified that a variety of models
currently exist in NSW but all agree that a more rapid, aggressive approach to
management is required.This study provides the basis for future discussions.
Concurrent 20 – Themed Presentations
Friday, 15 August 2008: 1408–1425 h
TRANSIENT ISCHAEMIC ATTACK ASSESSMENT – EVALUATION OF A
COMMUNITY BASED MODEL
D Crimmins, M Andreson, T Clark, J Sturm
Northern and Central Coast Area Health Authority, NSW
Introduction: TIA is recognised as a medical emergency of the highest
order. Intervention with clinical investigation, medical and possible surgical
treatment, is relatively easy and achievable. But the barrier remains comple-
tion of these rapidly.We present an evaluation of a community-based model.
Methods: The CCAHS covers 350,000 people with 2 teaching hospitals
(Gosford and Wyong) both with established stroke units (Gosf.TPA service).
A point of care TIA service was established with standard protocols of inves-
tigation and treatment (GP’s, ED’s). High risk TIA’s are admitted to hospi-
tal. Treatment and investigations are commenced and completed before
referral to a neurologist (organised centrally, <72 h).
Results: Results of 125 patients treated from 11/2007 to 04/2008, includ-
ing timing of investigations, commencement of treatment, 1 month compli-
ance, depression/anxiety levels and clinical outcome are presented. All
patients were reviewed within 4 days, with greater than 90% of patients
having a CT Brain/CT Angiogram and commencement of triple therapy
prior to review. Clinical outcomes are in line with published overseas data
(specialised TIA clinics).
Conclusion: Our TIA service, incorporating a point of care model (utilising
GP’s, ED’s and community neurologists) appears to as effective as hospital-
based systems but more achievable for the wider Australian community (met-
ropolitan, regional and rural settings).
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Friday, 15 August 2008: 1425–1442 h
IMPROVING CAREER PATHS FOR CLINICAL RESEARCHERS: WHERE
DO WE GO FROM HERE?
Julie Bernhardt1,2,3, Lili Tang Shyn-Li1,3
1National Stroke Research Institute; 2La Trobe University, Melbourne,
VIC; and 3University of Melbourne, VIC
Background: Increasing numbers of clinicians from nursing and allied
health backgrounds are pursuing research higher degrees; however, research
career paths in these disciplines are poorly developed.
Aim/methods: To survey all established physiotherapist researchers,
describe their career paths and seek their views of how research career paths
could be improved in the future. Target group were all Australian physio-
therapists who had a completed Doctor of Philosophy (PhD). The 28 
question anonymous questionnaire sought; demographics, reasons for under-
taking a PhD and training information, current research role, current clini-
cal role, career satisfaction, information about the participant’s career path,
and suggestions of future career paths. A mix of closed and open questions
were used.
Results: Fifty six physiotherapist researchers (response rate 64%) completed
the questionnaire. Over half had completed training since 2000. An interest
in clinical research was the strongest driver for undertaking a PhD. Fifty two
percent worked in traditional academic roles. Those who pursued other
mixed clinical/research or pure research paths reported a lack of job security.
The four identified themes for improving current research career paths were:
(i) developing careers that allow mixed clinical/research and academic/clini-
cal roles; (ii) improved funding for training, particularly post doctoral posi-
tions and secure appropriately funded research positions; (iii) greater
cooperation between academic (university) and clinical researchers, and (iv)
development of more flexible research careers to accommodate those wishing
to combine clinical work with teaching and research.
Conclusion: A vibrant research culture fosters professional excellence.
Developing better research career paths that link with the clinical practice
domain is our next challenge.
Concurrent 20 – Themed Presentations
Friday, 15 August 2008: 1442–1500 h
MULTIDISCIPLINARY APPROACH TO CAROTID STENTING IN A
PUBLIC HOSPITAL
CS Mak, N Roberts, D Clark, M Molan, M Brooks, G Fell, GA Donnan,
BR Chambers
Austin Health, University of Melbourne, National Stroke Research 
Institute, VIC
Background: Stroke neurologists, vascular surgeons, interventional neuro-
radiologists and interventional cardiologists have embraced carotid artery
stenting (CAS) as a carotid revascularisation technique with potential advan-
tages over carotid endarterectomy (CEA).
Methods: At Austin Health, a multidisciplinary neuro-interventional group
was formed to involve all interested specialties, standardise indications, and
to facilitate training. A clinical protocol was developed to ensure optimal
management. CAS was performed on patients at high risk for CEA, with
technically difficult anatomy for CEA and randomised to a stenting trial.
Results: From October 2003 to February 2008, 47 patients (34 male, mean
age 71.5) underwent stenting of 50 carotid arteries. 43 cases had ipsilateral
carotid territory symptoms within the previous 12 months. 17 cases were
high risk for CEA with 21 were randomised to stenting. There was proctor-
ing in 27 cases. There were 47 procedural successes with 2 cases abandoned
because of anatomical problems and 1 because of angina. There were pro-
cedural difficulties in 15 cases (30%). 31 cases (62%) had complications
including 17 with hypotension. During follow-up of 1–48 months (mean 15.9
months), restenosis occurred in 13% (none symptomatic), and there were 4
vascular-related deaths (2 each from ipsilateral stroke and cardiac events), 4
non-fatal strokes, and 1 non-fatal cardiac event.
Conclusion: A multi-disciplinary approach to CAS may be a useful strat-
egy for initiating and sustaining a carotid stenting programme.
Concurrent 21
Concurrent 21 – Invited Speaker
Friday, 15 August 2008: 1300–1330 h
THE GENETIC CAUSES OF STROKE
William R Wilcox
Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles,
CA, USA; and Department of Pediatrics, UCLA School of Medicine, Los
Angeles, CA, USA
Stroke in adults frequently has an underlying genetic basis. In the general
population, stroke is caused by the interaction of environment and a combi-
nation of many common genetic risk factors for atherosclerosis, hyperten-
sion, diabetes, coagulopathies, autoimmune disease, cardiomyopathies and
arrhythmias.When stroke occurs at a younger age, there is an increased like-
lihood of a dominant genetic contribution. Younger individuals with stroke
should be evaluated for recognizable genetic disorders that can affect other
organ systems. Common genetic disorders featuring stroke include homo-
cystinuria, hereditary haemorrhagic telangectasias, cerebral cavernous mal-
formations, CADASIL, CARASIL, pseudoxanthoma elasticum, familial
amyloidosis and mitochondrial syndromes. Recently, Fabry disease, a lyso-
somal storage disorder due to alpha-galactosidase A deficiency, was identi-
fied in 5% of younger stroke patients. Fabry disease also causes renal failure
and cardiomyopathy. Non-cerebrovascular involvement can be effectively
treated with enzyme replacement therapy.
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THE 25-YEAR FALL IN THE RISK OF STROKE ASSOCIATED WITH
ASYMPTOMATIC SEVERE CAROTID STENOSIS AND IMPLICATIONS
Anne L Abbott
National Stroke Research and Baker Heart Research Institutes, 
Melbourne, VIC
Background: Vascular disease medical (non-surgical) intervention has
changed bringing into question results of randomised trials of carotid
endarterectomy (CEA) for asymptomatic carotid stenosis.
Aim: To measure stroke risk associated with non-operated asymptomatic
severe carotid artery stenosis.
Method: A Medline search of prospective studies of non-operated >50%
asymptomatic carotid stenosis with sufficient data to calculate average annual
rates of ipsilateral stroke with/without TIA. Temporal changes in event rates
and baseline risk factors were examined using weighted ordinary least squares
regression analysis to account for varying study sample sizes.
Results: Ten studies were identified involving a total of 3539 patients (62%
male, mean age 64 years). Rates of ipsilateral (and any territory) stroke
(with/without TIA) fell significantly and progressively since the first studies
about 25 years ago (P < 0.001). Most recently, average annual rates of ipsi-
lateral stroke for non-operated patients were statistically no different from
rates of operated patients in randomised surgical trials. In addition, over time
mean patient age increased, the proportion classified smokers decreased
while those classified as hypercholesterolaemic increased (P < 0.001).
Conclusions: The 25-year fall in stroke rate in non-operated patients is likely
due to improved efficacy of vascular disease medical intervention and asso-
ciated more favourable patient risk factor profiles. If recent estimates of stroke
risk reflect outcomes in current clinical practice and surgical stroke/death
rates match randomised trials, then additional CEA is no longer helpful.
Most recent stroke risk estimates for non-operated patients may underesti-
mate what can be achieved non-surgically because comprehensive risk factor
therapy has not been described.
Concurrent 21 – Platform Session
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HYPERINTENSE ARTERY SIGN, ATRIAL FIBRILLATION AND INFARCT
SUBTYPE IN THE THIRD INTERNATIONAL STROKE TRIAL IST-3
RI Lindley1, PAG Sandercock, JM Wardlaw, MS Dennis, S Lewis on
behalf of the IST-3 Collaborative Group.
1The University of Sydney, Australia and The University of Edinburgh,
UK
Background: Response to thrombolysis may differ between large artery
infarcts (TACI, PACI) associated with atrial fibrillation (AF) compared with
subtypes associated with sinus rhythm (SR). We measured the frequency of
atrial fibrillation in the 4 Oxfordshire Community Stroke Project Classifica-
tion (OCSP) subtypes and whether AF was associated with the presence of
the hyperintense artery sign (HAS), an indicator of large artery occlusion.
Methods: We analysed data from the first 1,000 patients recruited in IST-
3. OCSP subtype and AF were assessed at baseline before randomisation.
Pre-treatment scans were assessed centrally by an expert reader, blinded to
clinical and treatment details.
Results: 247 of the first 1,000 patients were in AF. AF was more frequent in
large artery subtypes (TACI: 32%; PACI: 22%; LACI: 9%; POCI 25%). Of the
770 patients with complete imaging analysis, 36/148 (24%) of those in AF had
a visible HAS compared with 121/465 (26%) of those in SR (non-significant).
The pattern of HAS sign by OCSP subtype was similar in AF (TACI: 26%;
PACI 10%; LACI 0%) and SR (TACI 32%; PACI 17%; LACI 3%).
Conclusion: A quarter of IST-3 patients were in AF and AF was associated
with large artery, anterior circulation OCSP subtypes. Within each subtype,
the presence of AF did not increase the prevalence of HAS. IST-3 will provide
evidence on whether AF with or without HAS modifies the response to
thrombolysis. If disappearance of HAS after treatment indicates recanalisa-
tion, IST-3 will also provide information on the frequency of recanalisation
in different clinical syndromes.
Concurrent 21 – Platform Session
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THROMBOLYSIS FOR STROKE – WHAT ARE THE ‘GREY AREAS’ OF
UNCERTAINTY AND ARE THEY CHANGING? RESULTS FROM THE
THIRD INTERNATIONAL STROKE TRIAL IST-3
RI Lindley1, PAG Sandercock, JM Wardlaw, MS Dennis, S C Lewis on
behalf of the IST-3 collaborative group.
The IST-3 Trial Co-ordinating Centre, The University of Edinburgh, UK
and 1The University of Sydney, NSW
Background: Thrombolysis is approved for use in selected patients. IST-3
seeks to determine whether a wider range of patients may benefit.
Methods: IST-3 is an international, multi-centre, randomised controlled trial
of intravenous rt-PA in acute ischaemic stroke within 6 h of onset. Patients
are eligible if the clinician considers the treatment is, for that particular
patient ‘promising but unproven’ in addition to usual criteria (see details at
www.ist3.com). We aimed to describe (i) the baseline characteristics of the
patients (the ‘grey area of uncertainty’); and (ii) whether this has changed
since the start.
Results: A total of 1000 patients had been randomized by 16 December
2007. 69% were aged >70 years and 42% >80 years. Median NIHSS was 11
(IQR 6–17). Infarct subtype was TACI (45%), PACI (37%), LACI (13%) &
POCI (5%). Median time to randomization was 4.0 h (IQR 3.3–4.8). In each
consecutive series of 250 patients, there was no significant change in the
median time to randomization, (times varied between 3.9 and 4.3 h). The
age of the patients has increased, with 36% over 80 years in the first 250
patients compared with 52% in the most recent 250, TACIs have decreased
from 57% to 43% and LACIs increased from 8% to 13%.
Conclusion: IST-3 is chiefly recruiting the categories of patient in whom
additional randomized evidence is most needed (age > 80, 3–5 h, LACI,
POCI), and the proportion of patients in this clinically important ‘grey area’
have increased over the course of the trial.
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VALIDATION OF A SIMPLE DIAGNOSTIC METHOD FOR IDENTIFYING
OBSTRUCTIVE SLEEP APNEA (OSA) IN PEOPLE WITH HIGH CARDIO-
VASCULAR RISK
RD McEvoy1, D Gantner2, JY Ge4, LH Li4, NA Antic1, S Windler1, 
K Wong3, E Heeley2, SG Huang5, P Cui6, JG Wang4, CS Anderson2
1Adelaide Institute for Sleep Health, Repatriation General Hospital and
Flinders University, Adelaide, SA; 2The George Institute for Interna-
tional Health, NSW; 3Woolcock Institute of Medical Research, Royal
Prince Alfred Hospital and University of Sydney, NSW; 4Shanghai Insti-
tute of Hypertension, China; 5Department of Respiratory Medicine,
Ruijin Hospital, Shanghai Jiaotong University School of Medicine,
Shanghai, China; and 6Ruijin 2nd Road Community Health Center,
Luwan District, Shanghai, China
Introduction: There is uncertainty over whether treatment of OSA can
prevent cardiovascular (CV) disease. In developing the Sleep Apnea cardio-
Vascular Endpoints (SAVE) study, a large-scale randomised controlled trial
of CPAP therapy in high CV risk subjects, we validated a simple, low-cost
method of identifying ‘moderate-severe’ cases of OSA.
Methods: Consecutive high CV risk subjects were identified from a com-
munity health clinic register in Shanghai, China. They were invited to 
complete the Berlin sleep questionnaire (BQ) and undergo simultaneous
overnight in-home sleep studies with polysomnography (PSG) and a simple
OSA diagnostic device (ApneaLinkTM) that recorded oximetry and nasal
pressure. Questionnaire and ApneaLinkTM results were compared with PSG-
derived apnea-hypopnea index (AHI), and receiver operating characteristic
(ROC) curves were generated to assess the relative accuracy of oximetry and
nasal pressure in identifying OSA (AHI > 30 events/h).
Results: Of 257 eligible high CV risk subjects, 190 completed sleep studies
of which 143 were of sufficient quality for analyses to show OSA in 43%.
The BQ had high sensitivity (91.9%) but low specificity (25.9%). ROC
curves for oximetry and nasal pressure were 0.933 and 0.933, respectively.
At optimal diagnostic thresholds, oximetry and nasal pressure measurements
had similar sensitivity (83.9% vs 85.5%) and specificity (84.0% vs 85.2%),
but technical failure was lower for the former (5.8% vs 18.9% of tests).
Discussion: In high CV risk subjects, overnight single-channel oximetry and
nasal pressure measures provide high diagnostic accuracy and offer an acces-
sible alternative to PSG in screening for OSA. The BQ adds little diagnostic
utility. The ApneaLinkTM is used to identify eligible patients for the SAVE
study.
Concurrent 21 – Platform Session
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CEREBRAL WHITE MATTER LESIONS AND THE RISK OF INCIDENT
FALLS – THE TASMANIAN STUDY OF COGNITION AND GAIT
(TASCOG)
Velandai Srikanth1,2, Richard Beare1, Leigh Blizzard2, Thanh Phan1, 
Jennifer Stapleton3, Jian Chen1, Michele Callisaya2, Kara Martin2, 
David Reutens1
1Dept. of Medicine, Southern Clinical School, Monash Medical Centre,
Monash University, Melbourne, VIC; 2Menzies Research Institute, 
University of Tasmania, Hobart, TAS; and 3School of Psychology, 
University of Melbourne, Melbourne, VIC
Background: The prevalence of ischaemic cerebral white matter lesions
increases with age. Although lesions are postulated to increase the risk of falls
in older people, this has not been prospectively demonstrated before.
Objective: To determine whether greater white matter lesion volume is asso-
ciated with incident falls.
Methods: This is a prospective, population-based study with an electoral
roll-derived random sample of older people (n = 294, mean age 72.3 years).
Volumetric magnetic resonance imaging was obtained at baseline and inci-
dent falls were recorded prospectively over a 12 month period. Using regres-
sion modelling, we estimated the risk of incident falls associated with base-
line white matter lesion volume.
Results: Increasing baseline white matter lesion volume was independently
associated with any incident fall (p = 0.008) and multiple falls (p = 0.01).
The risk of incident falls was approximately doubled in people with lesion
volumes in the highest quintile of its distribution compared with the lowest
(adjusted relative risk 2.18, 95% confidence interval 1.27, 3.71).
Conclusions: These data provide the first prospective evidence demon-
strating that age-related cerebral white matter lesions may be causal risk
factors for falls in the general older population. They present potential ther-
apeutic targets for interventional trials in falls prevention.
Concurrent 21 – Platform Session
Friday, 15 August 2008: 1445–1500 h
MANAGEMENT OF DYSPHAGIA IN AUSTRALIAN STROKE UNITS
PC Langdon, ER Dunkin
Sir Charles Gairdner Hospital, Nedlands, WA
Background: Dysphagia in acute stroke has a reported incidence of up to
78%1. It is associated with an increased risk of pneumonia, especially in
patients with known aspiration (risk ratio 11.56).1 In mortality models for
ischaemic stroke, dysphagia is a significant predictor of death at 30 days.2 It
is a predictor of poorer outcome and need for residential care3, increased
length of hospital stay3 and 1-year and lifetime costs.4
High-intensity dysphagia therapy yields favourable outcomes in acute stroke
patients, with significantly fewer patients needing modified diets, dying or
requiring residential care by 6 months post stroke.5
Aims/Hypotheses: We sought to determine dysphagia incidence, prevalence
at 7 days and dysphagia management practices of Speech Pathologists in Aus-
tralian stroke units.
Methods: A questionnaire was developed by the authors, supported by the
National Stroke Foundation and Speech Pathology Australia and posted to
Australian stroke units. Follow-up letters were sent to non-responders after
1 month.
Results: Participation rate was 44%. 70% of respondents reported dyspha-
gia incidence of 41%–80% and 7-day prevalence of 21%–60%. Many patients
received daily dysphagia therapy (55%); 45% received therapy 2–3 times
weekly. The overarching factor limiting access to therapy was reported as
‘Inadequate FTE’ (full time equivalent) (87%). Many respondents com-
mented that poor conscious state in the acute phase is preventing active par-
ticipation in rehabilitation.
Conclusion/Discussion: This survey revealed a large percentage of Aus-
tralian stroke unit patients present with dysphagia. Despite compelling evi-
dence for intensive dysphagia therapy5 this does not always occur.
References
1. Martino R, Foley N, Bhogal S, Diamant N, Speechley M,Teasell R. Dys-
phagia after stroke: incidence, diagnosis and pulmonary complications.
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TOWARDS MORE APPROPRIATE OUTCOME MEASUREMENT IN
ACUTE STROKE TRIALS: DICHOTOMIZATION VS SHIFT ANALYSIS
Leonid Churilov
Stroke community is facing a very interesting and important debate on what
constitutes the appropriate outcome measure for phase III acute stroke trials.
This debate is crucial for both research and clinical practice as its results
would have a strong impact on the way the therapeutic interventions for
stroke are assessed. To become well-informed observers and, possibly, par-
ticipants in this debate, stroke researchers and clinicians require systematic
insight into relevant concepts and methods.
One of the most commonly used end points for assessing treatment effi-
cacy in phase III stroke trials is the Modified Rankin Scale (mRS) score.
mRS data have previously been analyzed by dichotomization of the scale to
define treatment success versus failure. An alternative outcome measure for
stroke trials is a favorable shift towards better functional outcomes in the dis-
tribution of the mRS scores across the range of disabilities in the treated
group versus placebo control group.
The objective of this talk is to provide a non-technical overview of the
dichotomization vs shift analysis debate concentrating on relevance and valid-
ity of the proposed concepts of dichotomization and categorical shift, as well
as comparative strengths and weaknesses of respective analytical approaches.
It is important to recognize that the real utility of the treatment approaches
can only be effectively evaluated with the use of appropriate outcome mea-
sures that are clinically meaningful and relevant. At present, there is only
limited consensus on the level of outcome and the method of measurement
to be used. The debate continues.
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ROASTED-RURAL ORGANIZATION OF AUSTRALIAN STROKE TEAMS
– EMERGENCY DEPARTMENT PROJECT
AA Wright1,2, M McGrail2, P Disler3
1West Gippsland Hospital, Warragul, VIC; 2Gippsland Medical School,
Monash University, Churchill, VIC; and 3Bendigo Clinical School,
Monash University, Bendigo, VIC
Background: Most stroke victims will be initially assessed and managed by
junior doctors in our emergency departments.The stroke knowledge of these
doctors may influence the quality of care that stroke patients receive.
Aims: The Rural Organization of Australian Stroke Teams Emergency
Department (ROASTED) project sought to determine the effectiveness of a
practical intervention to improve the assessment and education of stroke
knowledge among our junior ED doctors.
Methods: We employed a prospective before and after study of two separate
cohorts (intervention versus no intervention) to assess the stroke knowledge
of our junior ED doctors and to test the effectiveness of an educational inter-
vention. The project took place at five sites in rural Victoria in November
2006. Both cohorts undertook the same two validated quizzes one month
apart. At the intervention sites two one-hour tutorials were conducted
between the quizzes and participants were encouraged to use a web-based
educational tool.
Results: Pre-project stroke knowledge was shown to be poor at all of the
participating sites. At the sites where no intervention took place no improve-
ment in knowledge was demonstrated (quiz 1 = 8.1, quiz 2 = 7.2). At the
intervention sites participants significantly improved their stroke knowledge
between quiz one (8.3) and quiz two (12.8).
Conclusion: Junior doctors have an inadequate knowledge of stroke.
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BOTULINUM TOXIN AND FUNCTIONAL ELECTRICAL STIMULATION
FOR IMPROVEMENT IN UPPER LIMB FUNCTION EARLY FOLLOWING
STROKE
S Faux, M Bowman
Sacred Heart Rehabilitation Unit, St Vincent’s Hospital, Sydney, NSW
Background: Botulinum Toxin (BTX) is used to treat spasticity in both
upper and lower limbs of patients following stroke. It aims to improve func-
tion, pain or nursing care by relaxing muscles with spasticity. Functional
Electrical Stimulation (FES) is an electrical impulse applied to paretic
muscles of stroke survivors aiming to strengthen those muscles and assist
volitional control.
Aims: This pilot study aims to explore whether using BTX used to weaken
muscles with high tone while FES is applied to antagonist muscles might
confer better volitional control of the previously spastic muscles once the
BTX has worn off. For example, to use the period of time with wrist flexors
paralysed by the BTX to strengthen antagonist wrist extensor muscle with
FES.
Methods: Two blinded assessor (neurologist and occupational therapist)
were asked to identify the NIHSS score and the Motor Assessment Score (7
– Upper limb) of patients within 6 – 10 weeks of stroke. The treatment was
then instituted with BTX to the upper limb and FES used on the antagonist
muscles for 4 h per day for 4 months.Then the blinded assessor would review
the patient and rescore the NIHSS and MAS7 score.
Results: In 3 out of 4 cases, no improvement in upper limb function was
recorded. In one case finger movement was recorded for the first time.
Conclusion: Protocols for the use of BTX and FES in early stroke may need
revision. Further research using functional fMRI may be advantageous in
determining the impact of early BTX and fMRI on neuroplasticity. A larger
RCT of this treatment may be warranted.
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USE OF ANTHROPOMETRIC MEASUREMENTS FOR BODY WEIGHT
ESTIMATION FOR STROKE THROMBOLYSIS
Kelly Coughlan, Casey Hair, Bronwyn Coulton, Christopher Bladin
Box Hill Hospital, Monash University, Melbourne, VIC
Background: For the majority of acute stroke patients it is impractical and
time-consuming to obtain real weight values in the emergency setting of
thrombolysis for ischaemic stroke. Often patients are unable to communicate
resulting in health professionals (HP) being forced to use visual weight esti-
mates. Previous studies have documented how unreliable these approxima-
tions can be which raises serious safety concerns regarding potential dosage
errors in the calculation of weight dependant thrombolysis.
Aim: To determine the accuracy of anthropometric measurements (AM)
[height, waist and hip circumference] when compared with HP and patients’
weight estimates and real weight values.
Methods: Prospective study of consecutive stroke admissions from January
– April 2007 (n = 113). Real weight and AM were completed within 24 h of
independent visual weight estimations from two HP and patient’s own weight
approximation. Patients transferred from another hospital or receiving pal-
liative care were excluded.
Results: Median age was 77.5 years, 50% were female. Mean weight was 86
(±20) kg males and 65 (±11) kg females. Of the 67% (55/82) patients able
to provide weight estimates, mean error was 3.8 ± 4.7 kg compared with HP
(i) 7.9 ± 6.6 kg, HP (ii) 7.8 ± 6.6 kg, and AM:5.4 ± 4.4 kg. Use of AM
reduced the proportion of inaccurate weight estimations >10% by HP from
49% to 36%. Mean time taken to perform AM measures was 2 : 12 (±61 sec).
Discussion: As expected patients own weight estimate was found to be the
most precise and should be utilised when available. Use of AM reduces some
amount of error and if time permits should be undertaken in the emergency
setting when calculating individual thrombolysis dosage.
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PRIOR STROKE KNOWLEDGE AND THE RESPONSE OF PATIENTS TO
THE ONSET OF STROKE SYMPTOMS
Ian Mosley, Marcus Nicol, Geoffrey Donnan, Helen Dewey
National Stroke Research Institute, Melbourne, VIC
Background: Stroke community awareness campaigns have focused on
developing public knowledge of stroke symptoms. However, delays in seeking
emergency assistance following the onset of stroke remain.
Aim: To identify associations between patient stroke knowledge, stroke
recognition and seeking ambulance assistance during a stroke event. We
hypothesised that among stroke patients: (i) There are associations between
stroke knowledge, stroke recognition and calling an ambulance. (ii) Factors
that impact on calling an ambulance can be identified.
Methods: For 6 months in 2004, all ambulance-transported stroke patients
arriving from a defined region in Melbourne to one of three hospitals were
assessed. Ambulance and hospital records were analysed. Patients and the
person who called the ambulance were interviewed.
Results: 198 patients were included in the study. Patients identified two or
more stroke symptoms (stroke knowledge) in 65% of cases but recognised
stroke as the cause of their problem in 31% of cases. Only 1% of patients
sought ambulance assistance for themselves. Patient stroke knowledge was
significantly associated with stroke recognition (p = 0.016); however, stroke
knowledge was not associated with a patient call for ambulance assistance.
Common reasons for not calling an ambulance themselves were 1) physical
incapacity (45%), 2) unawareness of the problem (29%) and refusal to act
(13%).
Conclusions: Only 1% of stroke patients sought ambulance assistance them-
selves.Virtually all patients were affected by the stroke reducing their capac-
ity to seek assistance. This result shifts the onus of acting appropriately
following the onset of stroke symptoms from the patient themselves to the
people around the patient.
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ISSUES OF STROKE MANAGEMENT IN CHINA
KS Lawrence Wong
Department of Medicine & Therapeutics, Chinese University of Hong
Kong, Prince of Wales Hospital
In China, there are more 2 million new strokes every year. Despite recent
improvement in the economic front, the standard of medical care in most
parts of China remains unsatisfactory. In major cities like Beijing and Shang-
hai, advanced technologies are readily available in many hospitals. However,
most rural hospitals do not have stroke units and trained doctors to manage
stroke patients. Further, upgrading of stroke care is hampered by the lack of
universal medical coverage.
Chinese are also prone to have certain stroke subtypes: intracranial ather-
osclerosis and intracerebral haemorrhage. Large scale epidemiological studies
are, until recently, lacking to help us understand the underlying pathophys-
iology and magnitude of the problem. QUEST is one of the many large epi-
demiology studies that will shed light into the many facets of stroke in China.
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